But then a pecuniary analyst named Elliot Favus appeared on the talk design b call. Favus worked as regards Lazard Capital, and announced that he was sitting in as regards Joel Sendek, who most of the time covered Dendreon as regards Lazard. Favus launched into a series of arrogate questions, suggesting that the FDA admonitory panel had been a contrived, and that the FDA would not approve Dendreon’s prostate cancer treatment. He kept asking whether the FDA admonitory panel had asked the “right question” barbarian the effectiveness of Provenge.
Then Joel Sendek, Elliot’s buddy at Lazard, got on the design b call and initiated a like cross-examination.
When Dendreon’s CEO tried to indulge, Sendek interrupted and asked again - Did the panel inspirit b supplicate the “right question”? on the aggregate The baffled indulge was, “Yes.” on the aggregate But Sendek kept asking. The FDA panel asked two questions. Do you meditate on it was the “right question”? Do you meditate on the FDA when one pleases embody to “change the question”?
This was mere eccentric. Is Provenge appropriate? And, is there “substantial evidence” of efficacy? on the aggregate Those are the two questions that admonitory panels perpetually inspirit b supplicate.
It was well-defined to announce what Sendek was up to. Federal regulations call for them to inspirit b supplicate those questions.
Change the give someone the third degree? Did Sendek allow that the FDA was someway dominant to remodel its regulatory standards? Did he embody cleverness that the FDA muscle not approve Provenge - not included any condition reprove that the earn had followed its admonitory panels’ recommendations in 97% of cases, and had not included any condition in the background rejected a panel-approved refresher in the cards as regards terminally discomfort patients?
And who was this Joel Sendek?
* * * * * * * *
Sendek is an analyst as regards Lazard investigating. Usually, these songs glory in the demise of some biotech coalition or nostrum. He is illustrious on Wall Street as regards spending his evenings trade Wall Street investors and shareholders, and in fact singing songs into their voicemail. For design, when Sendek unequivocal that an anemia refresher called Erythropoietin wasn’t dominant to earn it to furnish (or to patients pain from anemia), he gleefully called all he knew on Wall Street and began singing (to the align of American Pie):
Bye-bye, Erythropoietin pie.
I don’t identify what prevarication Sendek sings barbarian Dendreon’s prostate cancer nostrum, but his reports on Dendreon embody been noteworthy around a similarly on cloud nine pessimism.
Drove my broadening fly off to business with the pipe,
But the pipe went shrivel. Same goes as regards the reports on Dendreon published around Elliot Favus, who, until recently, worked with Sendek at Lazard.
In April 2009, a infrequent days in the background a Yahoo! communication quality bill predicted, bordering on to the flash, the”BEAR RAID” that shattered Dendreon’s sell expense around 65% in 75 seconds, Lazard brook unmindful of a asseveration that said that an “investigator in the begin Provenge study” had concluded that Dendreon’s treatment did not position. In the fancy two years that followed that talk design b call in March 2007, Lazard’s reports embody steadily predicted (in tones that seemed bordering on hopeful) that Dendreon’s treatment would be establish lacking to reach patients who were dominant of prostate cancer. This was severe term - assuming that the “investigator” was hot accomplishments upon my term participating in the “current Provenge study” or any other well-controlled look of Dendreon’s treatment. When Lazard was challenged to bring about such an crack, it changed the communication again.
But it turned unmindful of that Lazard had made “a blunder.”
When Dendreon supporters started hollering that there was no such “investigator,” Lazard changed the asseveration to present that an “expert” had concluded that Provenge does not position. Now the crack wasn’t blemish on saying that Dendreon’s prostate cancer treatment does not position.
If you can blemish the similarity between this “mistake” and the “mistakes” of CNBC’s Jim Cramer, it when one pleases not hit you to learn that Lazard’s investigating company man was then scuttle around a guy named Paul Noglows.
Instead, it was that Provenge was “mentioned cautiously” around this pernickety “expert,” who remained anonymous. Prior to joining Lazard, Noglows was the fore-part of investigating at IRG Research, an garb owned around Jim Cramer’s pecuniary term and investigating coalition, TheStreet.com. Then he went to position as regards Och-Ziff Investment Management, a hedge help managed around Dirk Ziff.
Elliot Favus, the Lazard analyst who teamed up with the singing Sendek to ends Dendreon, later resigned from that pursuit.
As you when one pleases retraction, Ziff was the guy who helped Jim Chanos (host to Ashlee Dupre, hooker of Jim Cramer’s A-one pen-pal Eliot Spitzer) start his hedge help empire - an empire that rarely employs Evan Sturza, the auxiliary who inured to to be in the merchandising of publishing investigating that predicted, with like joviality, the demise of medicines developed around companies that were included fascination around Michael Steinhardt (Cramer’s at scope merchandising partner; mentor to Chanos) and other cronies of Michael Milken and Ivan Boesky. And, of advance, Chanos met Ziff unreservedly Michael Steinhardt and Marty Peretz, who was Ziff’s Harvard professor; on the aggregate a concealed pen-pal of Boesky; an choleric defender of Milken; a crucial circumscribed fellow, along with Boesky, in Michael Steinhardt’s hedge fund; and the co-founder, along with Cramer, of TheStreet.com.
Ziff’, about, was also the auxiliary who improperly received-along with Chanos, Steve Cohen and others in their network, advanced copies of bite pecuniary investigating published around Morgan Keegan.
Study the coterie of uncouth barring selling as regards three years, as I embody, and you when one pleases get a load of that these relationships likelihood. And you when one pleases get a load of that the most egregious cases of furnish skulduggery - the dour vandalize to acknowledged companies done around journalists and analysts unreservedly these repeated and precisely-crafted “mistakes”; the hired thugs; the threats; the over-the-top dolour (sung gleefully); the unlooked-for bankruptcies, the orchestrated calamities, the uninterrupted listing of eccentric occurrences - an alarming amount of it can be traced to the unaltered irregularity of beady-eyed, Milken-loving mischief-makers. You when one pleases get a load of how these people position together.
* * * * * * * *
As you may embody gathered around rarely, Provenge has but to be approved around the FDA.
What eccentric occurrences embody contributed to this occur? What cataclysm was awaiting Dendreon as these seven “colorful” hedge help managers stocked up on brook options while unclothed barring sellers flooded the furnish with at least ten million phantasma shares?
Before I indulge those questions, we ought to fee someone back to identify some things barbarian the “philanthropy” of Michael Milken and a fast called ProQuest Investments. Despite latest on the aggregate averment that it decreases prostate cancer mortality around 38%, the treatment has but to be administered to patients, 60,000 of whom embody died in the two years since the FDA’s admonitory panel voted in Dendreon’s favor.
In 1993, Milken founded the Prostate Cancer Foundation, with a stated function to advocate advancements in the treatment of prostate cancer.
Ostensibly, ProQuest was founded around two men - Jay Moorin and Jeremy Goldberg.
In 1998, ProQuest Investments opened as regards merchandising with the specifically stated function to instal in companies developing treatments as regards prostate cancer. But the chap who is in actuality behind ProQuest Investments is Michael Milken.
It was Milken who delivered on the aggregate most of ProQuest’s untimely spine-tingling. Industry reports imply that Milken is the firm’s rainmaker. And it is Milken who brings ProQuest’s deals to the tableland. For a fancy while, the controlling shareholders in Novacea were ProQuest Investments and a help called Domain Associates.
One of those deals was a coalition called Novacea, rarely known as Transcept Pharmaceuticals. I allow it is appropriate to concoct that ProQuest and Domain are joint, overrule that the two funds not however instal in the unaltered companies, but upon my term share in the unaltered applaud.
One divulge states that the two funds “plot strategy” together.
Industry reports assert that Domain was the “mentor” to Proquest, and an investor in the help. on the aggregate Thus, it would be more on quarry to asseverate that the controlling shareholders in Novacea were first appointment, ProQuest Investments, and backer, ProQuest Investments (acting unreservedly Domain Associates). Rather, ProQuest and Domain every so often instal spine-tingling in themselves.
But ProQuest and Domain are not like most biotech investment firms, which scout unmindful of companies with ruddy treatments and instal spine-tingling in them.
For design, Novacea was founded around Eckard Weber, who works as an foreman and fellow of Domain Associates. The next aeon ProQuest and Domain had invested in a coalition called Novacea, which superficially had a ruddy treatment as regards prostate cancer. One aeon, there was no such phobia as Novacea.
This remote should embody overrule far-off monster bells. An accomplishment as regards Dendreon was considered to be a obstruction as regards Novacea.
But as regards a fancy while, the media and others believed that Novacea was a dour - upon my term, the most dour - oppose to Dendreon. By the unaltered sign, a cataclysm as regards Dendreon had the concealed to be a dominating furnish to Novacea’s shareholders. And this cataclysm did upon my term bring in a jumbo means as regards Michael Milken’s ProQuest Investments and Domain Associates.
In in facts in fact, Dendreon suffered explicitly such a cataclysm.
But ProQuest and Domain are no longer shareholders in Novacea.
* * * * * * * *
First, albeit, it is top-priority as regards us to carry culture barbarian Michael Milken’s prostate cancer merchandising, on the aggregate ProQuest Investments, and Michael Milken’s “philanthropic” garb, the Prostate Cancer Foundation.
That is on account of some eccentric occurrences that I requisite define in more detail.
As we identify, ProQuest Investments was superficially founded around two men - Jeremy Goldberg and Jay Moorin. In multifarious transactions, the pecuniary advisor to this coalition was Paramount Capital.
Prior to sublimity the ostensible co-founder of Milken’s ProQuest, Moorin’s most important accomplishment had been to overrule out as CEO of Magainin Pharmaceuticals, a coalition that later changed its appellation to Genaera Corporation.
Paramount Capital, as you when one pleases retraction, is owned around Lindsay Rosenwald, the auxiliary who inured to to arrogate his father-in-law (the “king of sell fraud”) scuttle D.H.
As you when one pleases retraction, Paramount’s corruption president was split backer a clip dealer at SAC Capital, the hedge help scuttle around Milken crony Steve Cohen. Blair, which was the dirtiest Mafia-affiliated brokerage on Wall Street - the unaltered brokerage whose president had been Michael Milken’s federal sales overseer, and whose merchandising mannequin had been to confirm phony biotech companies, then increase and ditch their stocks. You when one pleases also retraction that Cohen and Paramount wage-earner Joseph Edelman were immensity those seven “colorful” hedge help managers who held jumbo numbers of brook options in Dendreon as of March 2007.
When Dendreon became a “battleground sell,” Dendreon had no more than three “serious” competitors.
At the jeopardy of being recurrent, I when one pleases also jog the memory you that Lindsay Rosenwald controlled Cougar Biotechnology, a coalition whose well-controlled admonitory quality included four doctors joint with Milken’s Prostate Cancer Foundation. One was Milken crony Rosenwald’s Cougar Biotechnology. The third was a coalition called Cell Genesys, which I when one pleases interest to in well-earned advance.
The other was Novacea, controlled around Milken’s ProQuest Investments.
Magainin/Genaera, the coalition that was scuttle around ProQuest’s ostensible unseat greater than, Jay Moorin, had lots of dominating ideas. It also claimed to embody discovered a treatment as regards cancer. For design, it claimed to embody developed a technique to examine foot ulcers with a heart extracted from the African clawed frog. This treatment was patently derived from the livers of tropical dogfish sharks. And multifarious of these treatments were heralded in foam releases that suggested that regulatory go was explicitly all greater than the corner.
Indeed, a gigantic multifarious of Magainin/Genaera’s obliged treatments were derived from quirky wildlife.
Sometimes, the coalition announced that its treatments had already gained go - albeit in quirky locales. Presumably, Cubans are rarely free of lung cancer. Genaera’s lung cancer vaccine “was approved Jun 12 around the Cuban regulatory authorities.” noteworthy anybody of Genaera’s bullish foam releases.
For three decades, these foam releases appeared. Then the sell would drop. Many of them sent Magainin/Genaera’s sell into consider.
After that, there would be another foam announcement and the sell would be barbarian in the stratosphere. In in facts in fact, it not included any condition had a treatment approved around the FDA.
But in three decades, Genaera not included any condition brought a treatment to furnish.
Three emotional decades.
A stupendous income as regards the CEO, and far-fetched profits as regards anyone who done for those 30 years riding the volatility of Magainin/Genaera’s sell. Countless potions and serums derived from all demeanour of critter and jungle being. But not a distinct treatment was brought to furnish.
* * * * * * * *
Jeremy Goldberg, the other ostensible unseat greater than of Milken’s ProQuest Investments, was earlier A-one known as regards his value as the founding CEO of a coalition called Versicor, which purported to earn anti-viral medicines.
In June 2009, Genaera announced that it was dominant unmindful of of merchandising.
Among Versicor’s biggest untimely investors was Healthcare Ventures, a help that was founded around two at scope Johnson & Johnson executives.
Another untimely investor in Versicor was Schroder Venture Management, a element of the unaltered coalition that runs Schroder Wertheim, which was the overseer clearing fast as regards Euro-Atlantic, a Mafia-run brokerage that the Feds fasten down in the unpunctual 1990s.
It seems that a greatest of Heathcare Venture’s principals earlier worked as regards Luekosite, a biotech fast founded around Marty Peretz, the Boesky and Michael Steinhardt crony who launched TheStreet.com with Jim Cramer.
But Versicor’s most grave investor was a biotech coalition called Sepracor, which markets Lunestra, the sleeping pharmaceutical. Barberich, was also a dominating investor in Versicor.
Sepracor’s chairman, Timothy J. Barberich served as Versicor’s founding chairman, while Goldberg served as Versico’s founding CEO. Curiously, Barberich also bankrolled Atlantic Casino Cruises, a gambling garb that was being overrule up around a businessman named Adam Kidan and an suspected mobster named Anthony Moscatiello.
So Barberich was big cheese of Sepracor (a coalition that markets sleeping pills), and unseat greater than, along with Goldberg (who later “founded” Milken’s ProQuest Investments) of Versicor (which has but to bring about any drugs befit as regards brainpower consumption).
Moscatiello, who travels in an armor-plated Mercedes, has been pegged around the conduct as being the clip CPA to the Gambino Mafia blood.
Moscatiello overrule the coalition up. As the geste goes, Kidan masterminded Atlantic Casino Cruises. And Barberich was the overseer backer of the schema. Soon after Barberich invested his readies, Kidan, the businessman, entered into a gigantic amount to securing another casino, SunCruz, from a auxiliary named Konstantinos “Gus” Boulis.
Unfortunately, the schema not included any condition in actuality got far-off the array.
In well-earned advance, Boulis accused Kidan of pecuniary improprieties in the gigantic amount.
And Moscatiello was arrested.
Not fancy after that, Boulis was stimulus in the fore-part - attainment pattern. on the aggregate
* * * CHAPTER 8 * * *
Adam Kidan was named as a fancy in the brook unmindful of of one’s misery of Gus Boulis and was questioned, but not included any condition charged. Moscatiello, the suspected Mafia CPA, was charged with the brook unmindful of of one’s misery. Instead, he went to can as regards his dealings with Jack Abramoff, the disgraced Washington lobbyist. When he was released on parole, he disappeared.
Meanwhile, Jeremy Goldberg Nautical seaport Versicor and “founded” ProQuest Investments, Michael Milken’s agency as regards investing in companies that rumour has it embody treatments as regards prostate cancer. Lately, he has been featured on the in small screen program, “America’s Most Wanted.”
Barberich, chairman of Versicor, said he not entirely knew Moscatiello or Kidan, and however got conflicting up with as the chief backer of their casino because he’d seen an commercial in a newspaper.
Milken is barred from the securities toil, so gloaming albeit he seems to embody been chiefly executive as regards shape ProQuest, it is not surprising that he does not have all the hallmarks on ProQuest’s website.
And there are a infrequent other names that disappeared from the website after people began investigating ProQuest. Goldberg’s appellation isn’t listed either.
Among the missing are the names of the people who have seats on ProQuest’s admonitory quality of directors.
The screenshots put to shame that at the every so often that Dendreon was getting mauled in 2007, ProQuest’s admonitory quality included the following: Jonathan Simons, president and CEO of Milken’s Prostate Cancer Foundation; Howard Soule, foreman corruption president of Milken’s Prostate Cancer Foundation; Stuart Holden, medical fore-part of Milken’s Prostate Cancer Foundation; William G. Thankfully, we embody screenshots of the fund’s website, bewitched preceding to the whitewashing. Nelson, a doctor who sits on the “Therapeutic Consortium” of Milken’s Prostate Cancer Foundation; James Blair, overseer of ProQuest affiliate Domain Associates and a quality colleague of Milken’s Prostate Cancer Foundation; David B.
In other words, ProQuest Investments, which is Milken’s investment help (though Milken doesn’t announce people that), enjoys wonderful coincide with on the aggregate Milken’s “philanthropic” garb, the Prostate Cancer Foundation.
Agus, a doctor with Milken’s Prostate Cancer Foundation; and, definitively, a doctor (I’ll overrule up him shortly) who was the chairman of the “Therapeutic Consortium” of Michael Milken’s Prostate Cancer Foundation.
Which raises a give someone the third degree: What does the Prostate Cancer Foundation do with the readies that it solicits from high-minded people - not explicitly moneyed donors but also common folks who need to conflict cancer and supply what they can?
I do not proletarian to be dismissive of a grant. It has served as a forum as regards multifarious of the world’s greatest doctors to furnish cleverness, and it has raised awareness of a severe affliction. I am certain there are well-meaning people who position at the Prostate Cancer Foundation. All grant, anybody can talk, is eulogistic.
But that muscle be to think too little of Milken’s lover of “the game” - his repair to be a sportsman in the coterie. And since Milken himself is a prostate cancer survivor, anybody is of a reprove to allow that his invigorate in battling the affliction is up. It muscle also be to think too little of the pernickety coterie that Milken inhabits. For stature and power bow the acknowledged and soothe the ethics.
It is a coterie of people who repair readies, yes, but who perchance repair in greater array both stature and power.
If you are a evil-doer, to underline “the game” is with to be funny in cheek. But it is perchance also as basic as this: the evil-doer desires to close to no scandalize. To underline the stratagem and phony is more with to be funny in cheek quieten. He wants to be adroit to asseverate to himself, “I am grave. on the aggregate.I embody the go of others.”
Certainly, Milken has inured to his “philanthropy” to ingratiate himself with the business and the acknowledged at jumbo. I am noteworthy.
He is anybody of the infrequent convicted criminals who has returned to “prominence.” So, it seems, he has gotten anybody greater than on us. But “the game” is not included any condition greater than. He has won.
And in the representation of Deep Capture, delightful matters more to Milken than battling the affliction that split backer afflicted him. This muscle legitimatize why Milken’s Prostate Cancer Foundation in option to supported Novacea, a coalition whose controlling shareholders were Milken’s ProQuest Investments and its affiliate.
Yes, it’s all barbarian “the stratagem.”
This muscle legitimatize why Milken’s “philanthropic” garb snubbed its nose at Dendreon, a coalition that did not embody a drug as regards prostate cancer, but did bragging the most ruddy latest treatment available-a treatment that could embody been safely administered to patients repair away. As we when one pleases get a load of, Novacea’s treatment was more unquestionably to suffocate patients than recover them, but that does not likelihood when it’s all barbarian delightful “the stratagem.”
To sway the stratagem, of advance, anybody requisite embody allies - preferably miscreants who identify a eulogistic schema when they get a load of it.
As you when one pleases retraction, Perceptive Advisors didn’t explicitly endanger dominating, it also pounded Dendreon around exercising design b call options, flooding the furnish with millions upon millions of Dendreon shares. Perhaps that is why Perceptive Advisors, which is an affiliate of Milken crony Lindsay Rosenwald’s biotech empire, invested a jumbo calculate in Milken’s Novacea while serving as anybody of the seven Milken-network hedge funds that endanger dominating against Dendreon. Simultaneously, Milken crony Steve Cohen, whose at scope clip dealer was a corruption president of Lindsay Rosenwald’s Paramount Capital, flooded the furnish with at least 1.6 million Dendreon shares. It’s barbarian the exhilaration of pushing the limits.
But it’s not explicitly barbarian delightful the stratagem.
It’s barbarian being have bearing on - have bearing on to the extreme; have bearing on to the consideration of irrationality - and seeing if you can (ha! ha! ha!) fee someone back away with it. Blair - a fast whose on the aggregate president was Michael Milken’s at scope federal sales manager; a fast that was tied to the Mafia and indicted on 173 counts of securities fraud; a fast that was A-one known as regards fraudulently pumping and dumping biotech companies that had no essential nostrum whatsoever.
Perhaps that is why Milken’s Prostate Cancer Foundation went to exceptional lengths (delivering readies, organizing conferences, dispatching noteworthy doctors) to advocate a mostly untested prostate cancer treatment - a treatment (Abiraterone) that was superficially being developed around Cougar Biotechnology, the coalition that was controlled until recently around the above-mentioned Lindsay Rosenwald, who is not however the son-in-law of the “king of sell shark,” but also a at scope corruption chairman of D.H.
Yes, it’s all barbarian “the stratagem.”
Perhaps this also explains the eccentric occurrences that began in the Spring of 2007.
The first appointment two you embody already met.
* * * * * * * *
In the weeks after the FDA’s admonitory panel congregation on March 29, 2007, there were however three pecuniary analysts on the planet who were giving a “sell” rating to Dendreon’s sell. One was the song-singing Sendek of Lazard investigating, the garb scuttle around the at scope fore-part of investigating at a subsidiary of TheStreet.com, which was co-founded around Milken crony Marty Peretz, barring selling hedge funds, and Jim Cramer, the at scope hedge help overseer turned “journalist.”
The backer was Jonathan Aschoff, the doctor-impersonating shark who inured to to position as regards Sturza’s Institutional Research, a fast that specialized in publishing bite, argumentative pecuniary investigating on biotech companies as regards a network of barring sellers that included the likes of Jim Chanos (Sturza’s begin employer) and Michael Steinhardt (mentor to Chanos; son of the “biggest Mafia vacillating in America”; fellow of Milken co-conspirator Ivan Boesky; and incubator of Jim Cramer’s hedge fund). Shenouda’s arguments against Dendreon matched bordering on blemish on those of Aschoff and the singing Sendek, both of whom we embody shown to be let go of the Milken network.
The third pecuniary analyst who was bashing Dendreon in the come into being of 2007 was Maged Shenouda of UBS, the investment bank. So it is possibly important that Shenouda’s boss, the president of UBS investment banking, was (until March 2007) on the aggregate Ken Moelis, who had split backer been a dealer as regards Michael Milken’s company man at Drexel, Burnham, Lambert.
While this protйgй of Milken was president of UBS, the coalition had evolve into anybody of the more humbug banks in the coterie. Indeed, Moelis had been anybody of Milken’s most trusted and favored employees.
According to the Department of Justice, as regards design, UBS “systematically and deliberately” violated U.S. But, of advance, it was not uninspired Americans who hid their readies at UBS. law around recruiting Americans looking to cop unmindful of taxes. It was however the wealthiest of people, including hedge help managers, who stashed billions upon billions of dollars in mystery accounts at UBS, while perchance intriguing more genially of the bank’s other “services” as positively.
Specifically, the attorney complete suspected that UBS had, along with Refco, processed phantasma sell as regards Rhino Advisors, the hedge help whose overseer became a ephemeral from U.S.
Was anybody those “services” prohibited unclothed barring selling? In 2006, the Louisiana attorney complete filed court documents to compel UBS to let go greater than records that would arrogate indulge that give someone the third degree. law, living in Austria, his readies unquestionably stashed in mystery bank accounts, after his “unbridled” unregenerate unclothed barring selling destroyed companies that had been hobbled around phony “death spiral” PIPEs deals, multifarious of which were brokered around Milken crony Carl Icahn’s Ladenburg Thalmann. Specifically, Mitchel Guttenberg, who had sat on an elite 12-member panel that signed far-off on the contents of UBS’s pecuniary investigating, had explicitly been arrested around the FBI.
In March of 2007, when Dendreon’s prostate cancer treatment appeared to be on the intemperate slot to FDA go, and a UBS investigating analyst was trashing Dendreon, another engrossing commemoration was unfolding.
Prior to joining UBS, Guttenberg had not had a illustrious trade. Later, he worked at a second-tier bank called First Albany and brook in every so often at Axiom Capital, a fast that was split backer censured around the NASD as regards publishing fallacious pecuniary investigating on biotech companies. He started unmindful of in Wisconsin, where regulators identified that he was trading without a someone’s own validate. (More recently, anybody of Axiom’s brokers was charged with systematically defrauding mentally handicapped aforesaid fogies people). For design, it would embody been Moelis who promoted Guttenberg to the elite panel that signed far-off of UBS’s pecuniary investigating.
Moelis, the Milken protйgй who was president of UBS, stacked the bank with his cronies, multifarious of them at scope Milken employees, and had a propensity as regards hiring and promoting people who were a colouring unmusical all greater than the edges.
Soon after joining UBS’s pecuniary investigating panel, according to the DOJ, Guttenberg began illegally providing core cleverness barbarian the contents of soon-to-be released UBS investigating reports to a rope of hedge help managers and traders.
Previously, the SEC had investigated Chelsey Capital and a hedge help called GLG Partners as regards allegedly paying investment banks jumbo commissions (bribes) in furnish as regards knowledgeable about access to essential acknowledged offerings. Two of the traders who profited from Guttenberg’s tips worked as regards a hedge help called Chelsey Capital.
It is rid that GLG Partners (and perchance, around addition, also Chelsey Capital) is a colleague of the network of hedge funds that is the grounds of this geste. While it is tangled to announce from these emails whether GLG participated in the network’s fascination on Fairfax, Chanos certainly communicated with GLG barbarian the rank of that fascination. Thanks to a lawsuit that Canadian insurer Fairfax Financial filed against SAC Capital (run around Milken crony Steve Cohen); Kynikos Associates (run around the above-mentioned Jim Chanos), and other hedge funds in their network, Deep Capture has acquired copies of emails that Jim Chanos sent to GLG Partners.
In March, 2007, when Mitchel Guttenberg, the colleague of UBS’s elite 12-member pecuniary investigating panel, was arrested, the SEC stated that Guttenberg was at the center of “one of the most omnipresent insider trading rings since the days of [Milken co-conspirator] Ivan Boesky..” A infrequent days later, Moelis, the Milken protege, resigned from UBS to start his own investment bank.
At the every so often, anybody of Meditor’s clip traders was Andrew Billet, back then of SAC Capital, the hedge help scuttle around Milken crony Steve Cohen, who was anybody of the seven “colorful” traders who held jumbo numbers of brook options in Dendreon.
A infrequent months after that, French authorities busted another UBS insider trading faction, this anybody including UBS subsidiary UBS O’Conner; the above-mentioned GLG Partners; and a hedge help called Meditor Capital.
This bond would not be merit mentioning except as regards the in facts in fact that Steve Cohen is known to comprehend his at scope employees in his nationwide trading network, and in 2007, Meditor’s trading tended to scuttle homologue to that of Cohen’s hedge funds.
Moreover, in April, 2007, repair in the background some eccentric occurrences were to derail Dendreon, Meditor purchased 1.6 million shares in Novacea, the coalition whose controlling shareholders (Michael Milken’s ProQuest and Domain Associates) requisite embody known, as regards reasons that I when one pleases define, that they would earn readies on their investment in Novacea however in the commemoration that Dendreon’s treatment as regards prostate cancer failed to begin to furnish. Indeed, Meditor’s biggest share in purchases were in biotech companies - Onyx Pharmaceuticals, Vion Pharmaceuticals, Atherogenics, and Cypress Bioscience - that were also targeted around Cohen’s SAC Capital.
Aside from Meditor Capital, there was, in the come into being of 2007, however anybody other hedge help that made a dominating investment in Milken’s Novacea - a coalition whose prostate cancer treatment, we when one pleases get a load of, had no wager of reaching patients anytime without delay.
Perceptive Advisors, we identify, was anybody of the seven “colorful” hedge funds that held jumbo numbers of brook options in Dendreon.
The backer hedge help was Perceptive Advisors, managed around an wage-earner of Paramount Capital, whose corruption president was back then anybody of Steve Cohen’s clip traders. And Paramount Capital was owned around Lindsay Rosenwald, the Milken crony who controlled Cougar Biotechnology, another Dendreon “competitor” that claimed (with arrogate from Milken’s Prostate Cancer Foundation) to embody a treatment as regards prostate cancer, albeit that treatment had bordering on no cleverness showing that it could be safely administered to patients.
* * * * * * * *
I when one pleases fee someone back to those eccentric occurrences in a consequence.
So we can Rather start to get a load of a design - a design that is all the more engrossing when you embody connection as regards the eccentric occurrences that began in April 2007.
But first appointment let’s learn a colouring more barbarian that first appointment UBS insider trading faction - the anybody that was busted in March 2007, when a UBS researcher was bashing Dendreon. Tavdy, described as a “scrappy” Russian outlander, was a concealed pen-pal and at scope First Albany co-worker of Mitchel Guttenberg, the auxiliary who was a colleague of UBS’s elite pecuniary investigating panel.
In accrument to the Chelsey traders, the faction included two other miscreants - David Glass and David Tavdy, both of whom received over intimation of the contents of UBS’s pecuniary investigating. Tavdy earned a means from his trading, but patently unsatisfied, he had painted on his costly, high-speed motor yacht the appellation, “Enough is Never Enough.”
Glass had earlier done for most of his trade at Sterling Foster, which was anybody of the first appointment brokerages fasten down around the FBI when the subdivision began its crackdown on Wall Street outfits believed to be tied to the Mafia. Later, Glass helped a concealed pen-pal dash off the book as regards “Boiler Room,” the booming motion carbon copy barbarian a brokerage that specialized in spine-tingling far-off investors.
Glass beat it his pursuit at Sterling Foster repair in the background the FBI raided the fast, wonderful 20 of its brokers.
Glass was the first appointment anybody busted as regards his position in the UBS insider trading faction.
In the advance of this palaver, Glass mentioned Tavdy and Tavdy’s concealed pen-pal, Mitchel Guttenberg, whom Milken crony Ken Moelis had promoted to UBS’s pecuniary investigating panel, putting him in a feeling to illegally uncover the contents of upcoming UBS investigating reports.
The FBI unhesitatingly strapped him with a wire and dispatched him to accomplishments a palaver with a Wall Street greaseball named Larry McKeever, who had said that he was dominant to disclosure the UBS insider trading faction to the authorities unless Glass paid him a jumbo calculate of readies.
Specifically, Glass told McKeever that the attempted become fast wasn’t a eulogistic inkling because Guttenberg and Tavdy muscle discover unmindful of barbarian it. As Glass brook it, Tavdy “probably knows the appellation of Larry McKeever.”
In comeback, McKeever said of Tavdy: “Listen, Glass, I kid you not-he’s a fucking absolute chap. Glass was extraordinarily alert to notify McKeever barbarian Tavdy. I don’t dumfound in the towel a fuck if he’s tied into the Russian crush or whatever. My lips to your ears. I’ll discover that cocksucker, have an effect my words.
He don’t identify my appellation.”
At this consideration, McKeever appeared to embody had backer thoughts barbarian issuing threats to Tavdy, a guy who muscle be tied to the Russian crush. But it is engrossing to get a load of what a identified acknowledged relations stab can defend unmindful of.
McKeever nervously added, “How does he identify my appellation?”
* * * * * * * *
In March 2007, after the FDA admonitory panel voted in favor of Provenge, the singing Sendek, the doctor-impersonating Aschoff, and the auxiliary from UBS’s troubled investigating rat on were the however three pecuniary analysts in the coterie who were dismissive of Dendreon’s prospects.
Dendreon’s treatment was the first-ever vaccine as regards cancer. And it was the first-ever cancer group therapy that could quarry and arrogate the vaccinated scheme. It was the first-ever ruddy substitute as regards the ravages of chemo.
Although the cleverness suggested that it did not balk the unpreventable stop in some patients, but barely forestalled it, the treatment was genuinely original and seemed to embody the concealed to recover a overrule of people.
But Dendreon was a commonplace coalition that did not take how “the game” worked. So anybody muscle embody expected some media nervousness. The whispering hedge funds, along with their proxies - the song-singing, doctor-impersonating analysts - were more cultured. And most of them featured Sendek, Aschoff, or the UBS auxiliary voicing their contributor light air that Provenge was “dangerous” - that the cleverness was not enough, that there were less discomfort drugs in the pipe.
So the foam reports on Dendreon were infrequent in slew. And as the days went around we heard more and on the aggregate more barbarian this eccentric inkling that the Provenge admonitory panel had asked the “wrong question” - that the FDA muscle embody to “change the give someone the third degree.”
Dendreon’s enemies repeated their “talking points.” They stayed “on communication.” They manufactured the term, and the term was that the FDA explicitly muscle send someone away Dendreon’s supplicate.
But teeth of the uncanny term reports, Dendreon’s sell expense continued to sky-rocket. Rarely mentioned was the in facts in fact the FDA had not included any condition in the background rejected a refresher as regards dominant patients after its crack admonitory panel had voted as regards go.
And so, the hedge funds continued to collection on.
And millions upon millions of phantasma shares continued to freshet the furnish. Call options (such as those exercised around the above-mentioned Perceptive Advisors) were exercised in meet. By April 10, Forbes munitions dump was reporting that Dendreon, a coalition that then had a furnish lid of explicitly included $2 billion, had evolve into anybody of the clip three most heavily traded stocks on Wall Street - beating unmindful of Microsoft, Cisco, and Seagate Technologies. He told CNBC’s audience that they were witnessing a barring “squeeze,” - the sell expense was soaring as barring sellers scrambled to securing shares to act their positions.
On April 12, Jim Cramer tried to legitimatize away the augmentation in the sell expense. Cramer added that he was excitable of anybody hedge help overseer who had failed to securing counterbalancing design b call options at an gearbox adopt expense. In any box, Cramer seemed to be saying that it was explicitly a likelihood of every so often in the background the sell expense would send someone away again. This was possibly a citation to Edelman at Perceptive Advisors.
Cramer was repair barbarian that.
To the unfair, they were growing their positions - exponentially. But there was no barring “squeeze” - the barring sellers were not covering their positions. On April 4, 2007, all greater than 3 million Dendreon shares were sold barring. And more than 10 million shares were sold barring every aeon greatest up to April 12.
The next aeon, the slew of shares sold barring quadrupled - to 13 million.
It is a appropriate endanger that these barring sellers knew that something was dominant to craze Dendreon’s sell expense.
* * * * * * * *
Late that aeon - April 13 - a newsletter called The Cancer Letter published a in all likelihood own the coterie of letters that Dr.
And certain ample, on April 13, Dendreon witnessed the first appointment of some singularly eccentric occurrences. Howard Scher of the Memorial Sloan-Kettering Cancer Center had written to the Food and Drug Administration. Scher was anybody of the 17 doctors who had sat on the FDA’s admonitory panel, and his the coterie of letters - which was addressed to an FDA emissary commissioner and cc’d to then FDA Commissioner Andrew von Eschenbach and an FDA someone’s own named Richard Pazdur - argued vehemently that Dendreon’s prostate cancer treatment should not be approved. Dr.
This was eccentric as regards numerous reasons. Doctors who are contracted around the FDA to chair a treatment as regards a suppleness foreboding affliction decision their opinions during the admonitory panel congregation. For anybody, it was unprecedented as regards a doctor to onslaught the FDA after an admonitory panel had already voted on a treatment. At the stop of the congregation, they are invited to back up on two questions: Is the treatment appropriate? And, is there “substantial evidence” that the treatment muscle ameliorate the pizazz of patients? The back up is considered immutable.
When Dendreon supporters and prostate cancer advocacy groups-including Care-To-Live, a grandiose organizing that has done much to give publicity to Dendreon’s travails-saw Dr. When it’s done, the doctors are expected (as we when one pleases see) to begin domestic and abide by their opinions to themselves.
Scher’s the coterie of letters, they asked Francesco Marincola, a doctor who had sat on the Provenge admonitory panel, to dash off his own the coterie of letters in Dendreon’s defense. Marincola declined. Dr.
He said, “As you may positively assume.I share in multifarious of your opinions. Marincola added: “If it is unswerving (which I doubt) that some other colleague of the quality contacted the FDA afterwards, it is beyond my self-discipline. However, I strongly allow that my position as a colleague of the admonitory quality is to articulate my conception during the congregation [and that] it would be discomfort advised to power the FDA verdict beyond that consideration.”
Dr. But my live conception is that my credibility as a colleague of the quality when one pleases be less discomfort preserved if I dumfound in the towel my equitable conception at the every so often of the congregation and betray the FDA do their position afterwards.”
This, said Dr. Scher’s note is that, within days, it ended up in the hands of The Cancer Letter, a handbill whose subscribers comprehend a important slew of Wall Street investors. Marincola, was a likelihood of preserving the “integrity of the convert.”
* * * * * * * *
The backer phobia eccentric barbarian Dr. FDA employees are forbidden to argue the merits of medical products in acknowledged, and anybody dominating rationality is that term of such discussions can mere restrictive sell prices.
Scher’s the coterie of letters was reminiscent of an commemoration that had made The Cancer Letter illustrious in the coterie of biotech - an commemoration that had established The Cancer Letter’s famous for as an mouthpiece of barring selling hedge funds.
The handbill of Dr. That commemoration was the FDA’s verdict in 2001 to controvert go of a cancer refresher that had been developed around a biotech coalition called ImClone. Somebody had core cleverness that the FDA was dominant to send someone away ImClone’s cancer treatment, and that hot accomplishments leaked the cleverness to The Cancer Letter, which published it with gigantic hubbub.
News of the ImClone verdict was made acknowledged not around the FDA. In the days preceding to the handbill, barring selling in ImClone increased dramatically.
One of those friends was Martha Stewart, who was then known as regards her all-American, domestic lifestyle products.
Meanwhile, ImClone executives and their friends offloaded their shares. Stewart was accused of trading on her core cleverness barbarian the FDA’s ImClone verdict.
Others were more auspicious. Ultimately, she went to can as regards obstructing the DOJ’s inquisition into her actions.
A Congressional inquisition into the ImClone circumstance produced phone records that showed who had called ImClone in the days in the background the FDA’s verdict was made acknowledged around The Cancer Letter. Presumably, these three hedge help managers had gotten light air of the excitable geste in The Cancer Letter, and were trade to argue. These records put to shame that on December 27, 2001, ImClone received phone calls from three hedge help managers.
It should hit nothing that these hedge help managers were all members of a distinctively colorful Wall Street network. That, about, is the help that incubated the trading empire of Jim Chanos, who is rarely included inquisition as regards trading to the fore of reports issued around pecuniary investigating fast Morgan Keegan. One of the three hedge funds that called ImClone that aeon was Ziff Brothers Investments. Dirk Ziff, as you when one pleases retraction, was introduced to Chanos around Michael Steinhardt (Milken crony; Boesky partner; son of “the biggest Mafia vacillating in America”) and around Ziff’s Harvard Professor, Marty Peretz (Steinhardt partner; Boesky crony; Milken pal). As you when one pleases also retraction, earlier Cohen was the clip earner at Gruntal & Company, a Mafia-linked brokerage that owed its obduracy to Milken’s dirt checks fee as regards.
The backer hedge help that called ImClone that aeon was SAC Capital, scuttle around Steve Cohen, the Milken crony who is “the most dynamic dealer on the Street.” As you when one pleases retraction, Cohen is a Chanos collaborator (both received and communicated barbarian advanced copies of the unaltered Morgan Keegan reports, and they embody most of the time employed the unaltered tactics, and the unaltered thugs, to fascination the unaltered companies). While there, he was reportedly investigated as regards trading on core cleverness provided to him around Milken’s people at Drexel, Burnham, Lambert.
It is tangled to identify whether these three help managers acted on the mystery ImClone cleverness that The Cancer Letter made acknowledged without delay after they called ImClone.
The third help overseer who called ImClone that aeon was Carl Icahn, the Milken crony who founded the options amble of life at the Mafia-linked Gruntal & Company in the background sublimity a billionaire around brokering “death spiral” PIPEs financing in cahoots with unregenerate unclothed barring sellers, and around blackmailing companies with fee as regards from Milken and the Mafia-connected Zev Wolfson. We don’t identify because the SEC does not call for hedge funds to uncover their barring positions, as they do their fancy holdings.
* * * * * * * *
We do identify that in the days greatest up to The Cancer Letter’s handbill of Dr.
Short positions are, after all, a dominating mystery. Scher’s the coterie of letters, barring selling of Dendreon’s sell increased dramatically. Scher emailed his own the coterie of letters to the FDA. Indeed, as mentioned, barring selling of Dendreon quadrupled on April 5, the aeon in the background Dr.
At the unaltered every so often, unregenerate unclothed barring sellers churned unmindful of more phantasma sell.
Since “failures to deliver” are recorded three days after the phantasma sell was sold, this means that big amounts of unclothed barring selling occurred on April 5. SEC cleverness shows that at least 9 million shares “failed to deliver” on April 10. On each aeon greatest up to April 13, the aeon that Dr.
On April 10, Dendreon’s sell was trading at its elated of all greater than $25. Scher’s note was published in The Cancer Letter, between 9 million and 12 million phantasma shares “failed to deliver”. on the aggregate By April 12, the aeon in the background The Cancer Letter’s “scoop,” the sell had already nosedived to all greater than $18.
And as mentioned, Dr.
This trading was eccentric. Scher’s the coterie of letters was eccentric. Scher’s lobbying of the FDA was unprecedented and an affront to the “integrity” of the refresher go convert.
It wasn’t explicitly that Dr. And it was not explicitly that his the coterie of letters to the FDA promptly appeared in The Cancer Letter (just as The Cancer the coterie of letters had made acknowledged the FDA’s verdict barbarian ImClone).
Scher’s the coterie of letters was in the works. And it was not explicitly that barring selling hedge funds unequivocally knew that Dr.
It was that Dr.
Like the Wall Street analysts, Dr. Scher’s the coterie of letters blemish on echoed the contributor light air that had been brook unmindful of around the whispering hedge funds, the song-singing Sendek, the UBS researcher, and the doctor-impersonating Jonathan Aschoff.
Scher said that Provenge had failed to foregather its “primary end-points in two clinical trials” - that the cleverness was not conclude “proof” that Provenge worked. Scher argued that the FDA would be someway habitat a reject criterion around approving a latest conventional of treatment. And explicitly as Aschoff had told journalists that it would be “dangerous” to approve Dendreon, Dr.
Dr. Scher, too, was suggesting that the admonitory panel had someway been a contrived - that it had “changed the question” notwithstanding the efficacy of Provenge. Scher’s the coterie of letters was also reminiscent of that Dendreon talk design b call, when the singing Sendek asked, greater than and greater than, whether the admonitory panel had asked the “right question” and whether the FDA muscle embody to “change the give someone the third degree.” Now Dr. Since the panel had voted on the fall through “question,” Scher argued, the panel’s irresistible counter-signature of Provenge should be disregarded.
Scher, who is anybody of the most noteworthy cancer doctors in America, was parroting the medical rationality of Wall Street goons.
It seemed that Dr. Either that, or the goons were parroting Dr. Whichever the box, and whatever their motivations, Wall Street miscreants and a noteworthy FDA-contracted doctor were rarely working in homologue to produce null a ruddy treatment as regards prostate cancer. Scher.
* * * * * * * *
Here’s another factoid barbarian Michael Milken’s ProQuest Investments. Screenshots from the background allowed me, in a aforesaid cut up of this geste, to announce you who most of those directors were as of Spring, 2007. As I mentioned, ProQuest whitewashed its website, so that it no longer identifies the directors of its admonitory quality.
But there is anybody ProQuest fore-part whom I embody not but identified around appellation. And his appellation is Howard Scher.
This ProQuest fore-part is a doctor.
That is conventional: Dr. In in facts in fact, Dr. Howard Scher, who sat on the admonitory panel that voted on the merits of Dendreon’s prostate cancer treatment, and then trashed Dendreon’s treatment in a the coterie of letters to the FDA (an unprecedented lobbying creation after an admonitory panel had voted), was also a fore-part of Michael Milken’s ProQuest Investments.
Scher was not explicitly a fore-part of ProQuest, he was also an foreman of the help, which unquestionably means he stood to profit from its investments. Scher was, not however that, the on the aggregate chairman of the “Therapeutic Consortium” at Michael Milken’s Prostate Cancer Foundation.
Dr. He also received uncharted amounts of readies as the furnish investigator of Asentar, the prostate cancer treatment that was being developed around Novacea, whose controlling investors were Milken’s ProQuest Investments and its affiliate, Domain Associates. Scher was a paid colleague of the admonitory quality of Cougar Biotechnology, the Dendreon oppose that was controlled around Milken crony Lindsay Rosenwald, back then of the Mafia-connected pump-and-dump sell shark rat on D.H.
Meanwhile, Dr. Blair. It is confusing to identify that Lindsay Rosenwald, a Mafia-connected Milken-crony with a accomplishments of destroying essential companies and creating humbug companies, is immensity the biggest biotech players in the civic entity - a sportsman who controls 8% of the world’s pharmaceutical firms.
It is dismal ample that the world’s best pecuniary unregenerate, Michael Milken, stood to profit from the demise of a ruddy prostate cancer treatment. It is perturbing to identify that this crony and those seven Milken-network hedge funds with jumbo numbers of brook options were no falter inclination on seeing Dendreon be establish lacking. Scher took unprecedented steps to derail a competing treatment that could embody extended the lives of a gigantic multifarious men.
But someway, the saddest term of all is that Dr. Dr.
He is considered anybody of the world’s best experts on prostate cancer. Scher is anybody of the most noteworthy physicians in America. His opinions likelihood. It is unquestionably that at some consideration Dr. His term is heeded. Scher believed that other treatments were sterling to Dendreon’s, but somewhere along the light air, he seems, at least to some stamping-ground, to embody betray his motives evolve into conflicting in with his incentives. Scher possibly should not embody sat on the FDA admonitory panel that voted on whether Dendreon should be approved.
Given his connections to Milken’s ProQuest Investments, to Novacea (the coalition controlled around ProQuest and an affiliate) and to Dendreon’s other competitors (such as Cougar Biotechnology), Dr. He certainly should not embody been lobbying the FDA.
He had what they design b call.well, in more sinless times, they called it a “conflict of interest”
* * * * * * * *
Maybe we should not be too well-defined on Dr. He should not embody trashed Dendreon’s treatment, as regards as he requisite embody known, well-earned to these other relationships, he could no longer beseech to be an goal eyewitness. Scher. The owners of the brokerages were dismal guys (there was a consideration where they to all intents began murdering each other in the streets of Bangkok), but they had evolve into entirely noteworthy in some merchandising circles. I am reminded of a geste that I split backer reported as regards Time Magazine in Asia, barbarian a network of Mafia-connected sell brokerages that had overrule up rat on in Bangkok, Thailand in repair to refrain from the FBI “Mob on Wall Street” crackdown that led to Operation Uptick in 2000.
They were also fantastically high-minded “philanthropists.”
The dismal guys gave extraordinarily jumbo sums of readies to a cleric who was illustrious as regards the wonderful position he had done to arrogate people in Bangkok’s most dire slums. Even when the dismal guys were charged with crimes - gloaming when they became fugitives from the law - the cleric spoke entirely strongly in their defense. The cleric was, of advance, appreciative as regards the contributions, and he inured to every break to convey approvingly of his benefactors.
He fully refused to accept that the criminals were anything other than “prominent” businessmen and “prominent” philanthropists. He was as eulogistic as they aggregate b regain.
The cleric was not a dismal chap.
But he had received so much readies - and he had deployed this readies to so much eulogistic intention - that he was of a reprove to carry working with the criminals. He was an grave decision of justice hegemony.
The illustrious cleric should embody condemned the miscreants.
But around the wonders of brainpower psyche, he mayhap believed, entirely genuinely, that the criminals had done no fall through. His judgment was clouded. on the aggregate We design b call this furor “deep intriguing.” The cleric had been “captured” around the criminals.
Perhaps Dr. Michael Milken’s Prostate Cancer Foundation had donated tens of on the aggregate millions of dollars to Dr.
Scher was a cleric of the medical community. Scher’s clinic, Memorial Sloan-Kettering (a clinic, it should be noteworthy, around technique of disclosure, that has also received important donations from the blood of Deep Capture news-hawk Patrick Byrne, whose cancer was successfully treated there). Scher and Memorial Sloan embody been adroit to carry their investigating into experimental treatments that perchance when one pleases anybody aeon arrogate patients.
With help from the Prostate Cancer Foundation, Dr.
No falter, Dr. No falter, he was determined barbarian his Milken-financed investigations and believed that he was contributing to the advancement of scheme. Scher was appreciative as regards this generosity. Meanwhile, Milken and his founding had evolve into entirely “prominent” players in the conflict against prostate cancer.
Nobody had more power. Indeed, it is even-handed to asseverate that Milken, more than anyone, had aggregate b regain to control greater than the prostate cancer business. So, in Dr. As his collaboration grew, he perchance became indissolubly tied to the position - not explicitly financially, but also emotionally. Scher’s representation, it perchance made fully realized feeling to participate with forces with this unregenerate.
The furor of “deep capture” is upon my term omnipresent.
That said, Dr. And it is omnipresent because it can overburden anyone - gloaming those with the A-one of intentions. Scher’s the coterie of letters to the FDA was not barely the position of an determined but “captured” physician.
It trashed Dendreon in a demeanour that was patently humbug, and exaggerated the guarantee of a treatment (the anybody included advance at Milken’s Novacea) that would without delay be shown to be incompetent. As we when one pleases get a load of, it was conniving.
Unwittingly or not, Dr.
And as we when one pleases get a load of, there are eulogistic reasons to fancy that those machinations were not barbarian grant or fighting cancer, or gloaming barbarian on the aggregate investing in companies that had up value. Scher aided the machinations of the unregenerate Michael Milken.
The machinations were barbarian destroying a eulogistic coalition so that Milken and a network of hedge funds could earn a dominating rope up together of readies. Scher made rid in his the coterie of letters, his plight barbarian Dendreon was not, strictly speaking, that it didn’t position, but that it would produce non-germane his position on Novacea’s competing treatment, Asentar.
* * * CHAPTER 9 * * *
As Dr. A latest light air up 3 whack to probe the effectiveness of Asentar (referred to in the the coterie of letters around its medical appellation, DN-101) had been “designed, initiated and continues to accrue,” Dr. “I am the International Investigator on this whack.”
Nowhere in his the coterie of letters (and nowhere in the conflict-of-interest death-watch fee someone back develop that he submitted in repair to fee someone back a residence on the FDA admonitory panel that voted on Dendreon’s treatment) did Dr. Scher wrote. Scher call that he was not explicitly the furnish investigator in the Asentar trials, but also a quality colleague and foreman of Milken’s ProQuest Investments, which was, along with affiliate Domain Associates, the biggest investor in Novacea, the coalition that was developing Asentar.
Scher was the chairman of the “Therapeutic Consortium” of Milken’s Prostate Cancer Foundation.
Also Nautical seaport unmentioned was the in facts in fact that Dr. The “Therapeutic Consortium” helps Milken’s “philanthropic” garb referee which treatments and hospitals legalize its help. Scher’s Memorial Sloan are linked to the hospitals’ help of delineated treatments being developed around delineated Milken-affiliated companies. on the aggregate It is rid that the Prostate Cancer Foundation’s donations to hospitals such as Dr.
For design, in anybody common foam announcement, the Prostate Cancer Foundation stated that the “Therapeutic Clinical Investigation Consortium [the Milken Prostate Cancer Foundation garb of which Dr.
PCF contributions to Sloan-Kettering reached $18 million to assignation, mayhap more.”
In other words, Milken raised readies from off guard donors, including the uninspired folks who slipped banknotes into the buckets that the Prostate Cancer Foundation places disinvolved of supermarkets and shopping malls. Scher is the chairman] played an grave position around accelerating testing of this latest means [Abiraterone, the means developed around Milken crony Lindsay Rosenwald’s Cougar Biotechnology] in Phase II clinical trials.Right rarely, at MD Anderson and Memorial Sloan-Kettering, both NCI funded cancer centers, the Phase III trials of Abiraterone [Cougar’s treatment] are dominant on. Then Milken, with the help of Dr. Scher’s clinic, with the brainpower that Scher and his clinic would mete unmindful of their noteworthy names to drugs developed around companies in which either Milken or Milken’s friends were investors. Scher, directed that readies to Dr.
Keep in reprove that the prostate cancer drugs developed around Milken-affiliated companies were in the earliest stages of advance - there was not but much averment that they could arrogate patients.
Meanwhile, when Dendreon produced “substantial evidence” that its treatment could Rather start extending lives repair away, the Prostate Cancer Foundation and joint doctors diverted intimation from the treatment, and (in the box of Dr. But, as we when one pleases get a load of, there was lots of concealed as regards them to earn readies as regards Milken and his friends.
Scher) worked like mad to keep appropriate that the treatment would not reach patients.
* * * * * * * *
Remember, on March 29, 2007, when Dr.
This is not blemish on “philanthropy” in its purest fee someone back develop. Scher sat on the FDA’s admonitory panel, he was anybody of the 17 doctors who voted unanimously that Dendreon’s treatment was appropriate. Scher wrote a the coterie of letters to the FDA in which he argued that the treatment should not be approved. And two weeks later Dr.
As mentioned, this the coterie of letters was eccentric in that it was unprecedented as regards an FDA-contracted doctor to onslaught the FDA after an admonitory panel had already voted.
And the the coterie of letters was eccentric in that it was urbane, to the asseverate the least. It was eccentric in that the in all likelihood own the coterie of letters was promptly published around The Cancer Letter, an garb with a famous for as regards being an mouthpiece of barring selling hedge funds.
For anybody, Dr.
In his the coterie of letters to the FDA, he noteworthy that the admonitory panel had discussed the in facts in fact that Dendreon’s trials showed that 4.9% of patients treated with Provenge had efficient “cerebrovascular events” compared to 1.7% of patients who were overrule a placebo. Scher seemed to embody changed his reprove with regards to the aegis of Dendreon’s treatment.
The panel’s 17 doctors, Scher included, had voted unanimously that this was an all repair jeopardy as regards patients with a callous affliction - extraordinarily since, in other regards, Provenge appeared to be damned appropriate.
But Dr. on the aggregate But rarely Scher was insisting in a the coterie of letters to the FDA that these rare “cerebrovascular events” (few of which were fatal) were worrisome ample to mulct end-stage prostate cancer patients of a treatment that muscle enlarge their lives. Scher’s “cerebrovascular events” finesse of reprove was not latest.
As to the effectiveness of Provenge, Dr.
It was blemish on the unaltered canard that had been delivered to the foam around those dubious Wall Street players - the singing Sendek, and doctor-impersonating Aschoff, the troubled UBS, and the whispering hedge help managers. Scher averred in his the coterie of letters that Dendreon had not met its “primary end-points” and the cleverness was “not considered trusty.” He insisted that the treatment be delayed until Dendreon could produce “proof” that Provenge extended lives. As Dr.
This was unhealthy. Scher requisite embody known, probably ever in the background has cleverness on an experimental treatment shown trusty “proof” that the treatment works in every box. on the aggregate Neither nostrum nor scheme progresses around “definitive proof”.
Instead, the legally established criteria as regards FDA go (especially of treatments as regards life-threatening diseases) is that the cleverness put to shame “substantial evidence” that the treatment improves the pizazz of patients.
Even if trials do not foregather their “primary end-points,” the FDA most of the time approves treatments as regards callous diseases if the odds are nonetheless eulogistic that the treatments augmentation survival. This criteria - “substantial evidence” of increased unfailing survival - is referred to as “the Gold Standard” around FDA officials and doctors elated. The odds muscle not be 100 percent, but if they are 98 percent, or gloaming 51% percent, the treatment should be delivered to patients who when one pleases in another position decrease.
In any box, “it may be every so often we concentrate less on statistical consequence, and more on unfailing profit.” So said Dr. Most unquestionably, Dr. Scher himself, in an appraisal with a medical newsletter, explicitly a infrequent weeks in the background he wrote a the coterie of letters to the FDA harping on Dendreon’s statistical consequence. Scher was philosophical barbarian his trials of Asentar (the refresher included advance around Novacea, which was controlled around Milken’s ProQuest Investments and an affiliate) and Abiraterone (the refresher developed around Milken crony Lindsay Rosenwald’s Cougar Biotechnology).
In in facts in fact, as we when one pleases get a load of, Asentar was not explicitly unhelpful to patients. These trials had not yielded distinctively eulogistic results. During trials of the treatment, patients dropped absolute.
And, as Novacea later acknowledged, the emotional was rid: Asentar upon my term killed a important slew of people who were hoped to profit from it. They dropped absolute earlier than expected. Provenge on the aggregate increased “cerebrovascular events” in a commonplace slew of patients, but patients on Asentar died in such jumbo numbers that Novacea had to beat it its trials of the refresher. Scher, and the Wall Street hedge funds in actuality allow that Asentar and Cougar’s Abiraterone were sterling to Provenge when they began their fascination on Dendreon? on the aggregate Or were their attacks motivated around their pecuniary interests?
* * * * * * * *
It was not top-priority as regards Asentar to be given FDA go in repair as regards Milken’s ProQuest to earn heaps of readies from its investment in Novacea.
The give someone the third degree is: Did Milken’s Prostate Cancer Foundation, Dr.
As we when one pleases get a load of, the Milken blood had hatched a drawing to banknotes in on their Novacea sell, regardless of what the FDA had to asseverate barbarian the company’s prostate cancer treatment, and regardless of whether that treatment would at the end of the day be shown to suffocate an unpleasant slew of people. Blair, which was indicted on 173 counts of securities shark and was illustrious as regards pumping phony biotech companies), but also two of the seven Milken network hedge funds that were betting dominating against Dendreon.
Same goes as regards Cougar Biotechnology’s investors, who included not explicitly controlling shareholder Lindsay Rosenwald (who split backer helped scuttle the Mafia-affiliated D.H. Cougar’s treatment, supported around Milken’s grant and around the four Prostate Cancer Foundation doctors who sat on Cougar’s admonitory quality, was to all intents untested, but as we when one pleases get a load of, this did not balk the company’s investors from cashing in.
Investors in those companies did not call for FDA go to earn readies, but as we when one pleases get a load of, their money-making plans would embody been foiled if Dendreon had received go.
When Dendreon came included fascination, like plans to banknotes in had been hatched around investors in a coalition called Cell Genesys, whose experimental (and, we when one pleases get a load of, ineffective) treatment was promoted in a most quirky approach (which I when one pleases define in well-earned course) around Milken’s Prostate Cancer Foundation. In reading the Xerox of the FDA admonitory panel congregation that voted on Provenge in March 2007, anybody has to wonderment if on the aggregate Dr.
Among Dr. Scher-who led trials as regards not however Novacea and Cougar, but also Cell Genesys-knew of these money-making plans, and if this grasp excitable the lobbying he undertook at the panel congregation, and in the days following it. Scher’s more revealing statements at the admonitory panel congregation was this: “So if I start philosophical, am I denying a potentially justifiable means [Dendreon’s Provenge] to men who unequivocally call for it, the indulge is unfortunately I don’t identify. If the FDA approved Provenge, they said, it would evolve into the conventional of attend to. So I asseverate, positively, what if we meditate on that this in actuality should be at one’s fingertips, start philosophical barbarian the slew of agents that are currently included advance.”
This is the unaltered communication that was whispered in the ears of reporters, who eagerly transcribed it into their stories. This would be dismal because other treatments “under development” muscle be less discomfort. Scher referred to treatments “under advance,” there was heart-rending else he could embody been referring to other than the above-mentioned Asentar (Novacea), Abiraterone (Cougar Biotechnology), and GVAX (Cell Genesys).
The plight with this finesse of reprove is that there were mere infrequent other treatments “under advance.” And when Dr.
As mentioned, Dr. Novacea’s Asentar, we identify, was liquidation people. Scher was connected to all three of those companies. At the every so often of Dr. The cleverness showed that some of those 38 patients catchword their blood tests ameliorate, and Cougar Biotechnology trumpeted this cleverness in multiple foam releases, but there was zero averment that Abiraterone increased unfailing survival. Scher’s fascination on Dendreon, Cougar’s Abiraterone had been tested on a unalloyed of 38 patients.
GVAX had been tested on 80 patients, and some of them lived longer, but the cleverness did not but put to shame “substantial evidence” that GVAX was the rationality. The cleverness from the Dendreon trials had reached statistical consequence, and showed that Provenge reduced mortality.
All of these treatments had undergone however Phase 2 trials, whereas Dendreon had completed Phase 3 trials on 170 patients. In other words, not anyone of the competing treatments (all financed around Milken or Milken’s friends and promoted around Milken’s “philanthropic” foundation) had aggregate b regain anywhere concealed to achieving results like Dendreon’s. Scher was importunate - “a slew of alternatives [those “alternatives” being drugs included advance around Milken and his cronies with the arrogate of Dr.
But Dr.
Scher and Milken’s ‘philanthropy’, drugs that would authenticate, in every so often, to be inferior] were “currently included advance.” on the aggregate And so patients requisite not embody access to Dendreon’s refresher on the aggregate - a refresher that was adept of parsimonious lives repair away. Scher made on the aggregate “the question” a crucial shattered of his the coterie of letters to the FDA.
* * * * * * * *
To take the lengths to which some people went to derail Dendreon, it is top-priority to retraction the Dendreon talk design b call, when the singing-Sendek kept asking whether the FDA muscle embody to “change the give someone the third degree.” on the aggregate Others on Wall Street were whispering barbarian “the give someone the third degree,” the foam transcribed into their stories these unaltered whisperings barbarian “the give someone the third degree,” and Dr. All of them suggested that the FDA admonitory panel back up was faulty because the 13 panelists who had voted that Provenge worked had, in in facts in fact, voted on the “wrong give someone the third degree.”
The Xerox of the Dendreon admonitory panel congregation clarifies what was meant around all of this questioning of the “question”.
It is the law of the securing. As noteworthy, admonitory panels are perpetually asked to back up on two questions: Is the treatment appropriate? And, is there “substantial evidence” that the treatment is gearbox?
This is not explicitly extraordinarily. The 1962 Kefauver Harris Drug Amendments, ratified around the U.S. Those 17 included Dr.
Congress, stipulated that manufacturers of refresher products requisite put to shame a drug’s effectiveness around “substantial averment.”
On the first appointment give someone the third degree, “Is the treatment appropriate?” the admonitory panel had voted “yes”, 17-0. Scher (though, as has been explained, within weeks he was lobbying the FDA around raising doubts as to the aegis of Provenge).
But remarkably, hot accomplishments at the FDA admonitory panel congregation rewrote the “question.” The chairman of the panel present the give someone the third degree unmindful of fortissimo: “Does the submitted cleverness put to shame the efficacy of [Provenge] in the intended populace?”
Immediately, there was confusion.
The backer give someone the third degree to be addressed was, ergo, “Is there actual averment that the treatment is gearbox?” Dendreon had unequivocally met this conventional - the “Gold Standard” of providing “substantial evidence” of increased survival. This was not the unimaginative give someone the third degree.
Dr.
Did “establish the efficacy” proletarian that the panelists had to back up on whether the cleverness had proved, with 100% conclusiveness, that Provenge extended lives? No experimental refresher had everlastingly faced such a conventional. Scher interjected to asseverate that Dendreon’s trials had failed to foregather their “two acme end-points.” To this, the FDA’s common on the panel, Cecilia Witten, remarked that the FDA was excitable that the trials failed to foregather its two acme endpoints, but that was not the printing.
“You identify,” Witten said. The printing was whether the averment suggested that Dendreon’s treatment saved lives. “We’re overrule the supplicate based on survival.”
The chairman of the panel resumed with the unaltered give someone the third degree. “Does the submitted cleverness put to shame the efficacy.?”
Thus began the voting. “Again I’ll present it,” he said.
Dr. Maha Hussain, and two other doctors. Scher promptly voted, “No.” So did another physician, Dr. But confusion reigned. Alexander, said, “So that’s - so my back up is, I don’t identify what you would design b call that.”
A Dr.
One panelist, a delineated Dr. Chamberlain said, “Well, so I feeling at this consideration I’m not certain how to indulge this give someone the third degree. With the aegis cleverness and with what we’ve seen, I get a load of no rationality not to earn this refresher at one’s fingertips, but I don’t meditate on it’s 100 percent proven that it’s booming.”
A Dr. It’s not a yes or no give someone the third degree in my conception the technique it’s phrased. Chappell said, “There’s a in harmony heart-rending by heart-rending of credence, and ‘establish’ implies much more assuredness.you call for get a load of fit, to cite, at least to me, what you proletarian.”
A Dr.
Finally, the FDA’s common clarified. Alexander piped in, “Like is it a unexcessive falter, a curtain of a falter?”
At this, there was a overrule of mumbling and some tittering. “Yes,” she said, “the regulatory asseveration of kidnap is ‘provide actual averment.’ So that’s our conventional.
That resolved any doubts, and 13 of the 17 doctors on the panel confidently voted “Yes.” on the aggregate That is to asseverate, when the doctors voted on the conventional give someone the third degree - the give someone the third degree that was stipulated around law, as opposed to the give someone the third degree that had been tampered with - the irresistible consensus was that Dendreon’s treatment should be approved.
Is there actual averment that it works.”
The chairman of the panel responded, “So explicitly to earn mead what you’re asking, is there actual averment that the artifact is booming?”
“Yes,” said the FDA’s common. on the aggregate
* * * CHAPTER 10 * * *
On April 20, three weeks after the admonitory panel back up, and anybody week after Dr. “If the earn wants to inspirit b supplicate Dendreon as regards more cleverness, it certainly has some outs,” Herper wrote.
Scher’s note appeared in The Cancer Letter, Forbes paragraphist Matthew Herper published a geste arguing that there was a eulogistic wager the FDA would not approve Dendreon’s cancer treatment at once. “The FDA changed the phraseology of the give someone the third degree.”
Three days later, Dr. Scher, had promptly voted “No” on the contrived give someone the third degree, wrote a the coterie of letters to the FDA arguing that Dendreon’s treatment should not be approved. Maha Hussain, anybody of the panel doctors who, along with Dr. This the coterie of letters, like Dr. And this the coterie of letters, like Dr.
Scher’s, was addressed to FDA commissioners and was in all likelihood own. Sher’s, establish its technique to The Cancer Letter, which posted it as regards all to get a load of explicitly three days after it was written. Hussain’s arguments were blemish on the unaltered as those employed around Dr.
Dr. Scher and the whispering folks on Wall Street. “From the well-controlled and procedural aspects, in complete, it would have all the hallmarks that at the stop of the aeon what should conclude a recalcitrant verdict in any salubrious whack is the soundness of the averment as critically reviewed around an Advisory Committee.with rid conduct on the give someone the third degree posed to the panel within the framework of the regulatory guidelines and requirements of the FDA as regards go.” [Italics mine]
That is, Dr.
“The recommendations as regards go.are based on cleverness that can however be characterized as A-one as ’suggestive’ of conceivable profit,” she wrote. Hussain-like Dr. The supporters had also discovered Dr. Scher, the singing Sendek, and whoever was feeding the paragraphist Matthew Herper-was suggesting that the FDA panel had voted on the “wrong give someone the third degree.”
Meanwhile, Jonathan Aschoff, the physician-impersonating pecuniary analyst who’d overrule a quarry as regards Dendreon’s sell expense to reach a gross $1.50, was leading journalists that the FDA panel would not embody voted to approve Dendreon’s treatment if it weren’t as regards the “substantial” rewording of “the give someone the third degree.” On April 25, Aschoff issued another damaging divulge, this anybody asserting, split backer again, that the FDA would send to Coventry its panel because the panel had voted on the “wrong give someone the third degree.”
By this every so often Dendreon supporters were busily circulating transcripts showing that the FDA panelists had, in in facts in fact, voted on the acceptable give someone the third degree. Scher’s ties to Novacea, Cougar Biotechnology, Proquest, and Michael Milken, and began explaining to all and assorted that ProQuest and Novacea would banknotes in if Dendreon were not approved. Hussain, the backer the coterie of letters paragrapher, had also done position as regards the Milken-invested Novacea, and was a colleague of the “Therapeutic Consortium” of Milken’s Prostate Cancer Foundation. Moreover, the supporters had revealed that Dr.
On April 26, Matthew Herper of Forbes published another article - this anybody repeating the arguments in Dr. Herper, who had been told barbarian Scher’s conflicts of invigorate, had patently unequivocal to investigating. Hussain’s the coterie of letters. This inquisition seemed to embody conflicting up with nothing more than asking Dr. In his April 26 article, Herper reported that Scher’s spokesman said “that Scher had nothing to do with his the coterie of letters leaking [and appearing in The Cancer Letter], and that he knew of no blood members who would profit financially either technique if Provenge were approved.”
To running backstay Dr.
Scher if he had any conflicts of invigorate. Scher’s credibility, and to earn Dendreon’s supporters look dolt, Herper added that the supporters had suspected that “Scher’s partner works as regards a hedge help that muscle be barring Dendreon.This is not unswerving. The facts in fact was, Dendreon’s supporters had revealed that Scher’s partner had a cousin, Barry Lafer, who was a hedge help overseer. She works in brainpower resources as regards a nursing domestic coalition that could not conceivably profit honestly from any term barbarian Dendreon.”
Aside from ignoring Scher’s ties to Milken’s ProQuest Investments, which would profit handsomely if Dendreon were not approved, Herper misconstrued the cleverness barbarian Scher’s partner. Phone records legally obtained around Deep Capture put to shame that Scher called Lafer, at his chore, on April 23, while Herper’s article was in the works.
the Wall Street whispering and the conjectures of two conflicted doctors) made “Dendreon an gloaming riskier sell than other biotechs.” Herper added that according to unnamed “others,” Dendreon’s “studies do not occur to the neck most of the time required as regards go.”
Besides being fallacious, this was another technique of suggesting that the FDA panelists, all experts in their aficionado, voted in favor of Dendreon because they had misunderstood the standards as regards go.
But the most important consideration of Herper’s article was that “all this debate” (i.e.
They had been asked the “wrong give someone the third degree.”
* * * * * * * *
On April 29, Bloomberg News reported that Dendreon’s shares were being sold at “a accomplishments pace” as investors “bet the company’s experimental prostate-cancer refresher when one pleases be establish lacking to sway go from U.S. on the aggregate This anybody was from a University of Washington biostatistician named Dr. regulators.”
Then, on May 4, there was but another the coterie of letters. Thomas Fleming.
Gerson Lehrman has a wonderful merchandising mannequin which can A-one be described as “institutionalized bribery.” Clients, mostly hedge funds, sublease Gerson to brook doctors and other experts on the payroll. It is perchance trinket that Fleming had done position as regards Gerson Lehrman, an garb that is owned around at scope hedge help managers. In furnish as regards the payments, the doctors begin together to produce hedge funds with “insight” (some asseverate they produce core information) barbarian clinical trials of drugs that are marketed around acknowledged companies.
In anybody illustrious box that dimple generic refresher manfuacturer Biovail against Steve Cohen’s SAC Capital and other hedge funds in his network, it was unequivocally established that doctors hired around Gerson Lehrman on behalf of the hedge funds upon my term lied to reporters (which could positively legitimatize, of advance, why they were hired). The doctors also begin together to talk to reporters (and perchance also to the FDA) barbarian these drugs.
Like the letters from Dr.
Hussain, within days of its beginning Dr. Scher and Dr. Fleming’s note miraculously ended up in the hands of The Cancer Letter, which eagerly published it. Fleming.
“Reportedly Scher felt motivated to dash off the the coterie of letters after being kept fee someone back dominant the continually following the [advisory panel],” wrote Dr. “I also was kept fee someone back dominant the continually following the panel.”
In accrument to aware barbarian Dr. Fleming shared Dr.
Scher’s sleeping habits, Dr. Scher’s plight that approving Dendron’s treatment muscle derail Asentar, the refresher that was being developed around Milken’s Novacea.
By this every so often, Dendreon’s supporters (a rambunctious bunch) were screaming and howling barbarian the dishonesty of those who had suggested that the admonitory panel had been asked the “wrong give someone the third degree.” So the contributor light air changed a colouring. How “could anybody evident internal consistency at FDA if [Provenge] were to be approved in the background the [Asentar] whack?” Fleming asked. Now it was that the panelists who had voted in Dendreon’s favor requisite embody been someway messy. Fleming wrote.
Dendreon trials did not “provide ’substantial averment of efficacy’, Dr. “Rather at A-one, these trials produce plausibility of efficacy.”
I’ll go it to the reader to parse the stamping-ground between “plausibility” and “substantial averment.” But unequivocally, this the coterie of letters was but another eccentric likelihood.
* * * * * * * *
The SEC’s bite cleverness shows that more than 12 million Dendreon shares “failed to deliver” on May 10, 2007.
Four days later - May 8, 2007 - the FDA told Dendreon that it was, as regards rarely, rejecting the company’s supplicate as regards Provenge, a paradigm-shattering vaccine as regards those terminally discomfort with prostate cancer.
Given that traders are permitted three days to bring about sell in the background their trades are registered as “failures to purvey,” it is rid that hedge funds had sold the 12 million shares of phantasma sell on May 7 - the aeon in the background the FDA made its verdict. Of advance, we do not identify who the criminals were because, as earn a appellation as regards oneself as the SEC is troubled, unclothed barring selling is a dominating mystery. This suggests that criminals were excitable of this excitable verdict.
But we do identify that a gross 10 hedge funds held jumbo numbers of brook options (a endanger that the sell expense would fall) as of March 31, a infrequent days after the admonitory panel’s to all intents unanimous back up in Dendreon’s favor.
Seven of those hedge funds be a colleague of to a hurtful Wall Street network that is known as regards its prevision. Obviously, these were hedge funds with wonderful prevision relating to a long-shot commemoration (the FDA’s verdict to begin against the irresistible direction of its admonitory panel to approve a refresher as regards terminally discomfort cancer patients).
Several of those seven hedge funds embody been implicated in unclothed barring selling infractions.
Five of these hedge funds I embody already named. And whenever any of these hedge funds embody targeted a coalition, the coalition has inevitably been victimized around hot accomplishments producing a gigantic great amount of phantasma sell. All embody ties to Michael Milken or his concealed associates. They are: Bernard L.
Some embody ties to the Mafia. Madoff Investment Securities, Perceptive Advisors, Millennium Capital, Steve Cohen’s Sigma Capital, and Pequot Capital. On the aeon in the background that fascination, a barring seller named Anthony Elgindy called his agent and ordered him to liquidate anybody of his accounts, giving the criticism that a dominating commemoration was barbarian to fly off appointment.
In preparation as regards naming the sixth, we call for to hearken barbarian to September 2001, when two airplanes crashed into the matching towers of the World Trade Center, anybody airplane crashed into the Pentagon, and a fourth dove into a aficionado in Pennsylvania. Mr.
After the 9-11 attacks, that agent notified the FBI of Elgindy’s uncanny scintilla, and the FBI launched an inquisition.
Elgindy said that on the following aeon (that is, on September 11, 2001) the furnish was dominant to on the aggregate be defeated two-thirds of its value. In the advance of this inquisition, the conduct au fait that Elgindy had sold big amounts of phantasma sell, and that he routinely blackmailed and threatened companies that he was selling barring.
Ultimately, albeit, Elgindy was convicted and sentenced to 11 years in community home as regards the more attestable crimes of sell manipulation and paying bribes to two FBI officials who fed him cleverness from the FBI’s National Crime Information System (one of those FBI agents upon my term kept Elgindy excitable of the perfect of the inquisition into Elgindy’s bond to the 9-11 attacks).
The conduct also au fait that Elgindy had ties to incendiary outfits in the Middle East, and as regards a every so often prosecutors argued in court that Elgindy had over grasp of the 9-11 incommode. In June, 2009, it was au fait that the SEC’s inspector complete had begun investigating SEC officials who are also suspected to embody collaborated with Elgindy, either around providing core cleverness on commission investigations, or launching toxic, dead-end investigations of companies that Elgindy was selling barring. He split backer worked as regards a now-defunct Mafia-connected brokerage called Blinder Robinson (known on the Street as Blind’em, Rob-em), and a origin concealed to the Elgindy inquisition has told Deep Capture that, briefly in the background Elgindy appeared as regards sentencing, Russian mobsters self-conscious Elgindy to catchword far-off the empty of anybody of his own fingers as a redolent of not to squeal on other members of his network.
Elgindy, like Bernard Madoff on the aggregate (the Dendreon barring and Ponzi schemer who helped dash off the SEC’s rules on unclothed barring selling), is believed to embody ties to organized misdeed.
There is averment - including transcripts of Elgindy’s own Internet communication quality - that shows that Elgindy routinely attacked acknowledged companies in collaboration with delineated hedge help managers.
One of them was Jeffery Thorp, whose sire split backer worked with the Genovese organized misdeed blood to bring unmindful of a method as regards cheating Las Vegas casinos. A important slew of these hedge help managers were let go of the Milken network.
The government’s inquisition of Elgindy at the end of the day led to Thorp, who was charged in 2006 with providing phony “death spiral” PIPEs financing to 22 companies.
Recall that like “death spiral” PIPEs were arranged around Carl Icahn’s Ladenburg Thalmann, ending in the phantasma sell ruination of more than 20 companies. The SEC’s box, anybody of the rare instances in which the commission has identified a unclothed barring seller around appellation, makes it rid that Thorp sold big amounts of phantasma sell, finally destroying the 22 companies that had received his phony PIPEs. Icahn is the “prominent” investor who owes his rank as a billionaire to Michael Milken and the Mafia-connected Zev Wolfson. on the aggregate And Icahn is the “prominent” investor whose Mafia-connected at scope wage-earner was the at scope chap to get a load of Alain Chalem (a Mafia-connected unclothed barring seller) in the background Chalem’s fore-part was riddled with bullets around Russian mobsters. Icahn is also the “prominent” investor who, along with Ziff Brothers and Steve Cohen, called ImClone at the drop of a hat in the background The Cancer Letter published the “leaked” term of an FDA verdict.
Do you quieten not allow that this network has ties to the Mob? Consider that Thorp’s sire, in accrument to working as regards the Genovese organized misdeed blood, was the distinct most grave sportsman in the sell manipulation network that Milken operated in the 1980s. The FBI at the end of the day raided that company man, hauling away phone recordings and documents.
The sire, Edward Thorp, ran a hedge help called Princeton-Newport. Thorp was not finally charged, but the averment that the FBI retrieved that aeon featured prominently in the prosecution’s 98-count indictment of Milken.
Boesky is to a large credited with putting Milken away, but upon my term he provided the authorities with mere heart-rending cleverness. Indeed, people who worked on the box asseverate that the Princeton Newport averment was earn a appellation as regards oneself more grave to the prosecution than the information of Milken’s more illustrious co-conspirator, Ivan Boesky. When asked to produce more, Boesky told the authorities that he feared that he would be killed because Milken had “friends in Las Vegas.”
Do you quieten not allow that people in this network evident blemish on the unaltered callous tactics? Consider that when the FBI investigated Elgindy, it also stumbled upon a hedge help called Gryphon Partners.
In pleading red-faced, Daws said, “others at Gryphon made trades in some of the pertinent stocks, unaffiliated of me, and not at my instructing.” Daws was convicted. One of Gryphon’s portfolio managers, Jonathan Daws, was at the end of the day charged with participating in different barring selling schemes hatched around Elgindy and his bribed FBI means. on the aggregate No charges were at the drop of a hat filed against Gryphon. Like Thorp and the hedge funds introduced around Carl Icahn’s Ladenburg Thalmann, Gryphon provided its PIPEs financing aware that it would emotional sell prices to renounce.
However, in 2006, the SEC sued Gryphon as regards providing phony “death spiral” PIPEs financing to 35 companies. The hedge help then hammered the companies with unclothed barring selling, sending their stocks into “death spirals.” Most of the 35 companies were destroyed.
At any fly off to business, Gryphon Partners, the Elgindy-connected, PIPEs-financing, 35 company-destroying, SEC-sued, unclothed barring selling “death spiral” fee as regards edifice, was founded around G.
So, at this consideration in the geste, we embody identified more than 70 companies that embody been vaporized around “prominent” investors, all let go of the unaltered network.
Stacy Smith and Reid S. They rarely scuttle a hedge help called WS Ventures. Walker, two “prominent” investors who embody since gone on to greater things.
And WS Ventures is the sixth of our seven “colorful” hedge funds that had the prevision to own jumbo numbers of brook options in Dendreon at the stop of March 2007, explicitly after the speciously far-fetched term that the admonitory panel had voted overwhelmingly in Dendreon’s favor; and during the aeon when unregenerate unclothed barring sellers (don’t identify who they were; the SEC keeps that a dominating secret) were pounding Dendreon with phantasma stock; and explicitly in the background the dismal term that the FDA had, as regards the first appointment every so often in the background, rejected the term of its own admonitory panel to approve a treatment as regards terminally discomfort patients. on the aggregate
* * * CHAPTER 11 * * *
Who in the conduct helped destruction Dendreon? Despite the lobbying around the captured doctors, teeth of the Wall Street whispering, teeth of the singing Sendek and the media mimics - teeth of all of this, it quieten seemed unquestionably that the FDA would attend the term of its admonitory panel.
A infrequent months after that wonderful fascination, Dendreon, on the threshold of pass unmindful of and barbaric as regards readies to help its sabotaged prostate cancer treatment, went to the fore and signed a gigantic amount to be given its first appointment “death spiral” PIPEs fee as regards.
Instead, the FDA told Dendreon that it would not but approve its treatment - that the coalition had to fee someone back more cleverness, which would fly off years, around which every so often the coalition could of course scuttle unmindful of of readies. This was a eccentric likelihood. The FDA handed Dendreon (and prostate cancer patients) what seemed like a decease verdict. It requisite embody followed some dour position around conduct officials in elated places. Dr.
One someone’s own who muscle embody advocated against Dendreon was then FDA Commissioner Andrew von Eschenbach, who was a concealed associate of Michael Milken.
von Eschenbach was a founding fore-part of Milken’s Prostate Cancer Foundation, and later he was at the forefront of an finally luckless creation to bring around George Bush to award a presidential slacken humane Milken as regards his crimes.
Long in the background I came along, an omnium gatherum of Dendreon shareholders, prostate cancer patients, up folks on Wall Street (there are some), and troubled citizens spotted the connections immensity Milken, ProQuest and the captured doctors who led the lobbying creation against Dendreon. But it is rid that von Eschenbach was not the however someone’s own courted around Milken and his associates.
When the FDA failed to approve Provenge, these folks catchword that an inequality had been done, and they hollered loudly.
Care-to-Live (to whom I be indebted to a accountable of gratefulness as regards uncovering some of the cleverness that appears in this story) has not however chronicled Dendreon’s travails, but has also labored tirelessly to repair the wrongs. Soon after, a snitch roots organizing called Care-to-Live was founded to deliberation on Dendreon’s behalf. on the aggregate It has organized alley protests and letter-writing campaigns. In the advance of these efforts, it managed to fee someone back a hold up of different documents and email communications between Dr.
It has lodged Freedom of Information Act requests and it has filed a lawsuit against the FDA. Scher (the physician with pecuniary ties to Milken’s companies and “philanthropy”) and officials in the conduct officialism. Scher and his allies depended chiefly on help from a mid-level FDA wage-earner and a crucial wage-earner at the National Cancer Institute, which oversees conduct funding of cancer initiatives, and has illustrious, albeit unauthorized, power greater than FDA decisions.
What these documents and emails put to shame is that Dr. Over the years, Milken and his Prostate Cancer Foundation embody made gigantic efforts to ingratiate themselves with the NCI, which may be anybody rationality why Dendreon was not included any condition adroit to be given conduct funding, teeth of the original concealed of its treatment.
Scher, who was eager crafting the note that would be published with clandestine immediacy around The Cancer Letter.
On March 31, 2007, Alison Martin, who was in sortie of the prostate cancer splitting up of the National Cancer Institute, emailed Dr. “Glad to fee attention to the coterie of letters is being drafted,” Martin wrote. this is explicitly a in harmony in a convert.”
The “division” whose conceivable go of Dendreon’s treatment so discomfited Dr. “If that [FDA] division’s back up suggests [that Dendreon’s treatment] be considered as regards go, I was wondering if it then could begin to ODAC, which is more clinically savvy, i.e. Martin was the FDA’s Center as regards Biologic Evaluation & Research (CBER), which was assigned the business of evaluating Dendreon’s supplicate.
Richard Pazdur. Martin was suggesting that if CBER was dominant to approve Provenge, perchance the likelihood could be bewitched to ODAC - the FDA’s Oncologic Drugs Advisory Committee, which was led around an FDA someone’s own named Dr.
Pazdur has a concealed relationship with a Washington lobbyist named Samuel D. Some years ago, Turner, who helps scuttle an organizing called the Cancer Leadership Council, led a stab to embody Pazdur appointed as the commissioner of the FDA. Turner. Michael Milken supported that stab. Donald Coffey of the Prostate Cancer Foundation, embody collaborated closely with Turner in another cancer lobbying association called C-Change, of which the Cancer Leadership Council is an affiliate.
And Milken’s advisors, such as Dr.
As a occur of this help, Milken and Pazdur embody evolve into mere concealed friends. Congressional inquisition identified that Pazdur, unreservedly his lobbyist pen-pal Turner, had leaked core cleverness that the FDA was dominant to send someone away Erbitux, a cancer refresher that was developed around ImClone.
Some years ago, a U.S.
As you when one pleases retraction, that core cleverness made its technique to Martha Stewart, habitat in signal the bind of events that landed her in can. Scher’s “confidential” the coterie of letters to the FDA. The ImClone core cleverness also was first appointment published in The Cancer Letter, the unaltered mock that published Dr. on the aggregate And, about, the records of phone calls made to ImClone at that every so often put up the clear admissibility opportunity that funds managed around Milken cronies Carl Icahn, Steve Cohen, and Dirk Ziff also were privy to that cleverness in the background it was made acknowledged.
And without delay after Martha Stewart received the core cleverness, but in the background she was caught, hedge funds in the Milken network began barring selling Martha Stewart’s coalition, Martha Stewart Living Omnivision.
As an aside, after ImClone’s sell crashed on the term, the coalition was seized around Milken crony Carl Icahn. One proposition that explains the chaste timing of those hedge funds is that the funds knew Martha was dominant to be arrested and ergo shorted her coalition on the assumption that term of her apprehension would send someone away the sell.
But that is a geste as regards another every so often. They may gloaming embody been the ones who turned her in.
For rarely, it barely needs to be emphasized that Pazdur, the FDA someone’s own, has unusually concealed relationships with Milken and some of his cronies.
And with the pursuit name incitement of Dr. He was a crucial sportsman in the ImClone dirt, which displays wonderful similarities (such as insider cleverness mysteriously appearing in The Cancer Letter and the involvement of hedge funds in the Milken network) to the Dendreon dirt. Scher and Alison Martin at the National Cancer Institute, Pazdur appears to embody played a crucial position in derailing Dendreon’s prostate cancer treatment. Instead, because the refresher is a biologic, the verdict rested with the FDA’s Center as regards Biologics Evaluation and Research (CBER).
Pazdur was not obliged to be the anybody who unequivocal whether Dendreon’s refresher was approved.
Nonetheless, Pazdur inserted himself into the verdict convert. Scher and Dr. It was at Pazdur’s behest that Dr. Hussain were, teeth of their ties to competing companies controlled around Milken’s funds and friends, appointed to the admonitory panel that voted on Dendreon’s supplicate. Scher and Dr.
As you when one pleases retraction, Dr.
Hussain were immensity the four panelists who promptly voted “No” to the incorrectly phrased give someone the third degree barbarian Dendreon’s effectiveness. Maha Hussain, who then attempted to instill depth confusion, patently hoping that the panelists would carry voting on the incorrectly phrased give someone the third degree. When the phrasing was changed to the conventional, legally mandated give someone the third degree ( Is there “substantial evidence” that the refresher reduces mortality?) the unconsumed 13 experts on the panel voted “Yes.”
According to eyewitnesses, explicitly as panelists began noticing that there was something eccentric barbarian the give someone the third degree they were being asked, Pazdur began fleeting notes to Dr. Pazdur, who had aggregate b regain to the congregation uninvited and unannounced, also done for a eulogistic gigantic amount of every so often conversing with Dr.
Curious to identify whether it was Pazdur who finally derailed Dendreon’s supplicate, perchance gloaming delivering the captured doctors’ “confidential” letters to The Cancer Letter - and wondering whether this had anything to do with Pazdur’s relationship with Michael Milken - Care-to-Live, as let go of its lawsuit against the FDA, subpoenaed Pazdur’s pertinent emails and documents. Hussain, giving the power that they were working together to schema arguments that muscle bias the panel against Dendreon.
Pazdur responded included assure as follows: “I searched both my essay and computer files and was not able to lay any documents that were reactive to Plaintiff’s requests.
The documents were shredded and deleted within a month of comeback.”
This comeback was eccentric. I retraction receiving.these letters.However, as these letters mutual to a delineated regulatory supplicate conducted around a away FDA Center (CBER), did not renounce included my without handicap regulatory supervision.I shredded my well-defined copies of these letters and deleted any electronic copies. For anybody, Pazdur seemed to be stating that he had no involvement in the Dendreon verdict. In comeback to complaints that Pazdur had participated in a verdict that was obliged to be Nautical seaport to the CBER splitting up, the FDA said that he had done so “at CBER’s supplicate.” Clearly, Pazdur had been conflicting up with in the verdict, so it was urbane as regards him to assert in another position in his efforts to legitimatize why he had (frantically?) shredded and deleted all the pertinent documents. If that were the box, what was he doing at the admonitory panel congregation? on the aggregate Pazdur’s asseveration also contradicted an earlier asseveration from the FDA.
Moreover, if Pazdur is leading the facts in fact (and not, that is, fully obstructing justice), then Pazdur violated the kidnap of different initiatives, including a invoice passed in the U.S.
The rationality that conduct officials are asked to abide by eulogistic records is that they are every so often conflicting up with in controversies - controversies such as the anybody that was swirling all greater than Dendreon’s FDA supplicate when Pazdur began shredding and deleting documents so unhesitatingly and from stem to stern. House of Representatives and directives from the Archivist of the United States, aimed at ensuring that conduct employees refer to by records of their someone’s own merchandising.
In any box, most of the documents that Care-to-Live requested had been transmitted electronically, kidnap that a basic computer cut could embody retrieved them, gloaming if they were deleted. Pazdur had rationality not to let go greater than those documents. Clearly, Dr.
Perhaps he was advised not to around his advocate, who happens also to be the unaltered advocate who represents The Cancer Letter, the mock that published the “confidential” letters that Dr. Hussain wrote to Dr. Scher and Dr. Pazdur and FDA commissioners. And the email quoted chiefly strongly suggests that her drawing was to fee someone back Dendreon’s supplicate unmindful of of the hands of the designated hegemony, CBER, and into the hands of Richard Pazdur.
Fortunately, Alison Martin of the National Cancer Institute did not dumfound away the unalloyed - she handed greater than at least some of her documents. In comeback to that email, Dr.
In a consolidation email, Dr. Scher wrote to Martin that he, too, would assay to embody Dendreon’s supplicate “reviewed around ODAC” (which was controlled around Pazdur). Scher wrote: “Got a flash as regards excitable give someone the third degree mutual to FDA processes?”
A flash later, Martin responded: “Consider this own, get a load of fit.but I wanted you to identify.” As to what own cleverness she delivered to Scher, that is unclear from the documents received around Care-to-Live.
But other documents and emails put to shame that around untimely April, 2007, as the hedge funds were shape up their barring positions, Martin was fully betrothed in serving Dr.
Perhaps the leading documents were also unhesitatingly shredded. Scher design his the coterie of letters trashing Dendreon - the “confidential” the coterie of letters to the FDA that would be promptly published around The Cancer Letter. Scher’s the coterie of letters was establish on Martin’s computer. Indeed, a matching of a half-edited design of Dr. And in anybody email, Martin appears to threnody barbarian all the position she has done on this the coterie of letters.
So an wage-earner of the federal conduct was serving a conflicted doctor onslaught the federal conduct. “Maybe you should dash off a the coterie of letters, too,” she jokes.
That is, Martin, the fore-part of the prostate cancer element at the National Cancer Institute, was serving a doctor - a doctor with pecuniary ties to Michael Milken and to a competing, Milken-invested coalition - destruction Dendreon’s treatment as regards prostate cancer. Soon after, she was appointed president and chief foreman copper of the Melanoma Research Alliance (where anybody on the aggregate can safely fly off her compensation exceeds her aforesaid conduct salary).
As term of this started to reach Dendreon’s supporters, Martin Nautical seaport her pursuit at the National Cancer Institute.
The Melanoma Research Alliance was a appellation latest “philanthropic” garb.
Milken founded the Melanoma Research Alliance and hired Alison Martin with an essential award from Leon Black, the “prominent” billionaire and Milken crony who does merchandising with an suspected Russian mobster named Felix Sater. It had explicitly been overrule up around a “prominent Maecenas.”
The appellation of the “prominent philanthropist” is, of advance, Michael Milken.
Sater, about, is the auxiliary who allegedly was behind the presage to embody Deep Capture news-hawk Patrick Byrne murdered if Patrick did not stop his campaign against uncouth barring selling and the “deep capture” of the nation’s regulatory bodies.
This “investigation” entailed asking Dr.
* * * * * * * *
On May 11, three days after the FDA failed to approve Dendreon’s treatment, The Wall Street Journal published a divulge that purported to investigating the allegations that the conduct go convert had been compromised. Scher whether he had any conflicts of invigorate. Scher told The Journal.
“‘I assay to abide by to the elated array,’” Dr.
Apparently charmed with his interest, and choleric to assuage any suspicions that something nefarious had gone down, The Journal added that Dr. He and his partner hold up commonplace amounts of sell in Biogen, Idec and Pfizer.”
That was it. Scher “serves as an advisor to Innovive, a commonplace biotech not conflicting up with in prostate cancer, and works with Bristol-Myers Squibb in an passive aptitude on untimely rank drugs that may hold up guarantee in prostate cancer. According to the Journal, Scher had no conflicts of invigorate.
Scher was a quality colleague and foreman of on the aggregate Milken’s ProQuest Investments.
The Journal did not call that Dr. It did not call the in facts in fact that ProQuest was heavily invested in Novacea, a Dendreon oppose. Scher was greatest the trials of Novacea’s prostate cancer refresher, or that he was a paid fore-part on the admonitory quality of another Dendreon oppose - Milken crony Lindsay Rosenwald’s Cougar Biotechnology.
It did not call that Dr. And it did not call that Dr. Scher.
Scher was greatest clinical trials as regards but another Dendreon oppose, Cell Genesys, which, like Cougar and Novacea, was supported around Milken’s Prostate Cancer Foundation, whose “Therapeutic Consortium” was chaired around not anyone other than Dr.
The Wall Street Journal did not call any of this, teeth of the in facts in fact that troubled citizens had plastered the cleverness all greater than the Internet. Now it was someone’s own - Pazdur’s splitting up would embody some power.
Four days after the Journal article appeared- May 15, 2007 - the FDA issued latest guidelines as regards evaluating immunotherapy agents, such as Dendreon’s treatment.
This seemed like the FDA was papering greater than a dirt.
* * * * * * * *
Just a infrequent weeks after the FDA said it would not but approve Dendreon’s treatment, it was easier to take why Dr. If Pazdur had violated the guidelines around influencing the Dendreon verdict, rarely the FDA could asseverate that, in in facts in fact, there were latest guidelines, and Pazdur had followed them (never reprove that the latest guidelines were written anybody week after the FDA failed to approve Dendreon’s treatment, mayhap because Pazdur had violated the aforesaid guidelines). Scher, Milken and their allies were so choleric to get a load of Dendreon be establish lacking.
Within 24 hours, Novacea’s sell expense jumped 86 percent. On May 30, 2007, Novacea, the coalition whose largest investors were Milken’s ProQuest Investments and the joint Domain Associates, announced that it had signed a $500 million gigantic amount to jointly bring unmindful of its prostate cancer treatment with pharmaceutical leviathan Schering Plough.
In succeeding days, the merchandising media reported this “news” as if it were not explicitly a merchandising accomplishment, but also a dominating breakthrough in the coterie of nostrum.
“That all changed on Wednesday when the refresher maker announced it had signed a gigantic amount merit greater than $500 million with pharma juggernaut Schering-Plough.”
Forbes added that Novacea’s treatment “appears to significantly augmentation the wager of survival immensity androgen-independent prostate cancer patients.”
As this $500 million know and term of Novacea’s medical miracle made its technique all greater than the other term organizations, and appeared elated on the Internet, Novacea’s sell continued to sky-rocket. “On Tuesday, Novacea was explicitly another adolescent biotech, with a meek furnish capitalization of $187 million,” enthused Forbes munitions dump.
Nobody in the media paused to embody connection as regards whether a “$500 million deal” constitutes a medical breakthrough (like, as regards design, reducing mortality around 20% in late-stage prostate cancer patients, as Dendreon had done).
Furthermore, nothing in the media paused to embody connection as regards that had Dendreon received go as regards its competing treatment, this “$500 million deal” would bordering on certainly not embody happened.
The assumption was, if there is dominating readies and the sell is soaring, the company’s prostate cancer treatment requisite be eulogistic. Nor did anybody in the media divulge that the people (Milken and friends) who stymied Dendreon were the unaltered people who stood to profit from this purported “$500 million” gigantic amount. Novacea did not be given $500 million.
At any fly off to business, the gigantic amount was not entirely what it was made unmindful of to be. It received $60 million up fore-part.
By cashing unmindful of of the sell after it soared in value, Schering-Plough could significantly mark down that upfront investment. Meanwhile, Schering-Plough was overrule $12 million merit of Novacea sell at a eulogistic gigantic amount expense. The hit the hay of the much-trumpeted $500 million was dependent on Novacea’s clinical trials showing that its cancer treatment upon my term improved the pizazz of patients. It was liquidation patients.
Sure ample, explicitly a infrequent months later, in November 2007, Novacea announced that the clinical whack of its treatment had been terminated “due to an unexplained imbalance of deaths.” In other words, Novacea’s refresher was not improving the pizazz of patients. And as without delay as this term was released, the much-heralded $500 million Schering-Plough gigantic amount was cancelled. Given the gargantuan arrogate the sell expense had received after the “$500 million” term, it appears that on the aggregate ProQuest and Domain (i.e.
Either briefly in the background or without delay after the trials were terminated well-earned to an “imbalance of deaths,” Milken’s ProQuest Investments and Domain Associates sold their sell in Novacea. Michael Milken and friends) sold their sell at a important profit.
Scher (who worked as regards ProQuest and furnish Novacea’s clinical trials) in actuality allow that Novacea’s treatment was sterling, as he claimed during his booming stab to fee someone back the FDA to send someone away Dendreon’s refresher? Did Michael Milken’s Prostate Cancer Foundation, which was an addition of ProQuest and snubbed its nose at Dendreon’s treatment, in actuality allow that there were less discomfort treatments in the pipe?
Did ProQuest and its affiliate Domain, which founded Novacea, everlastingly attend to barbarian producing a marketable refresher? Or was Novacea a scam? A scam that was built on essential scheme (though Dr.
So the questions odds: Did Dr. Scher was less than upfront barbarian the results of his clinical trials, his efforts to bring unmindful of Novacea’s treatment were no falter sincere).
But nonetheless a scam - an old-fashioned increase and ditch scam. A scam that was more cultured than those perpetrated around the scuttle shops of yore, and whose every component may embody been technically acceptable. on the aggregate
* * * CHAPTER 12 * * *
“Black Wednesday at the FDA.”
That is how Dr. In an op-ed as regards the Wall Street Journal, Dr.
Mark Thornton, a at scope medical copper in the FDA’s Office of Oncology Products, described the FDA’s verdict not to approve Dendreon’s Provenge. Thornton described vaccines such as Provenge as the “Holy Grail of cancer treatment.” on the aggregate Without blemish on referring to anyone around appellation, Dr. Scher’s lobbying creation as “arrogant” and “unprecedented.”
Dr. Thorton described Dr. Thornton added that when the FDA succumbed to that lobbying, “the lineage of a latest aeon in cancer immunotherapy was driven barbarian into the continually. Some Dendreon supporters took to the streets. It when one pleases be years in the background we identify the emotional repercussions of these decisions and how multifarious cancer patients.have had their lives eschew barring as a occur.”
This dirt infuriated multifarious other physicians and unfailing advocates (with on the aggregate the rare of those joint with Milken’s Prostate Cancer Foundation).
On June 2, 2007, there was a fly off issue with in fore-part of the American Society of Clinical Oncology. On June 6, there was but another fly off issue with, this anybody attended around quieten more physicians who demanded to identify why the FDA had failed to approve Dendreon’s treatment. Two days later, certain prostate cancer advocacy groups rallied in Washington.
“I’d like to legitimatize in the most crucial of terms,” said Dr.
“We meditate on a blunder has been made. Mark Moyad of the University of Michigan medical fashion, at the June 6 meet. We are here in a accessible technique to start the convert of correcting that blunder.”
That term - “friendly” - seems to me to damned define Dendreon’s supporters.
“Oncologists do not most of the time call for bodyguards.” began a geste in the Washington Post, which was all barbarian the Dendreon “controversy.” on the aggregate The consequence of this geste was that people advocating as regards prostate cancer patients muscle someway be reject - that it was eccentric how vocal they were, it was eccentric that they inured to the Internet to fee someone back the term unmindful of - and Dr. I muscle unalloyed on the aggregate “intelligent,” and “fair,” and “engaged.” on the aggregate But the mainstream media played its conventional position around portraying such advocates as vexatious wackos (notwithstanding the in facts in fact that multifarious of Dendreon’s supporters were respected physicians). Scher (the physician who helped derail Dendreon) feared as regards his aegis. Nowhere was it mentioned that Dr. He had gloaming received some “threats.”
Nowhere in the geste was it suggested that a gigantic multifarious noteworthy doctors were saying that the FDA had made a “mistake” in wasted point to approve Dendreon’s supplicate. Scher played a important position in engineering this “mistake.” on the aggregate And nowhere was it mentioned that Dr.
Essentially comparable stories appeared in the Philadelphia Inquirer, the New York Times, the Boston Globe, the Seattle Times, and on CNBC.
Scher was egregiously conflicted well-earned to his pecuniary ties to Michael Milken’s investment help and Dendreon’s competitors, Novacea and Cougar Biotechnology. Every anybody of these media outfits portrayed Dendreon’s supporters as potentially reject lunatics. Scher had been “threatened.” on the aggregate Yet, not anybody of them specifically described the threats, and as earn a appellation as regards oneself as I can ascertain, there were no “threats.”
Clearly, there was a latest contributor light air - Dr. Every anybody of them stated unequivocally that Dr. Scher was the casualty.
Meanwhile, Dendreon remained anybody of the most manipulated stocks on Nasdaq.
Given the in word-for-word repetition of this contributor light air in so multifarious newspapers, and overrule my combustible working in the mainstream media, I can asseverate with in assuredness that this was the position of an orchestrated acknowledged relations stab - a stab to distract intimation from what was in actuality episode to Dendreon. On the aeon that the Washington Post geste appeared, SEC cleverness showed that unregenerate unclothed barring sellers had sold, and failed to purvey, more than 13 million Dendreon shares. There was no technique the coalition could put up more readies on the sell furnish, and so it had to significantly compass barbarian its position on Neuvenge, a ruddy treatment that fought boob cancer in the unaltered technique that Provenge fought prostate cancer. Following the mainstream media’s conventional operating procedures, no call was made of this phantasma sell in any of the stories on the Dendreon “controversy.”
* * * * * * * *
By June of 2007, Dendreon’s sell expense was averaging all greater than $7 - down from its untimely April elated of $25. In repair to fee someone back ample banknotes to carry position on Provenge, Dendreon issued greater than $100 million merit of convertible bonds.
But, every so often, hedge funds that securing convertible bonds do not embody the company’s A-one interests at pot.
Sometimes, hedge funds that securing a company’s convertible bonds are well-intentioned - they need the coalition to be successor to so that the coalition can recompense the allowance. Indeed, Deep Capture has obtained an internal unfailing donation overrule around a familiar investment bank that states that the distinct largest block of investors in convertible bonds are hedge funds that upon my term contemplate to augmentation their bets against the companies that they are financing. A hedge help lends a coalition, asseverate, $100 million.
A convertible checks is accountable that can be “converted” into sell. As repayment, the hedge help can either be given the $100 million advantage invigorate at completion, or in option to it can be given, asseverate, 10 million shares in the coalition.
But if the share in expense rises to $20, the hedge help can transfigure his $100 million allowance into $200 million merit of sell.
If the share in expense is $8 at the every so often of the allowance, those 10 million shares would be merit $80 million. If the hedge help overseer is a value investor who wishes the coalition positively, he when one pleases earn his allowance and hang around as regards the sell to occur. Suppose a association of hedge funds embody launched a emotional compass barring selling fascination against a coalition, but the hedge funds need to barring rep gloaming more sell.
But there are different ways that convertible bonds can be brook to malevolent contemn. on the aggregate To do that legally, the hedge funds requisite first appointment lay more sell to adopt, and then rep it.
Now, fly off the share in expense has already been significantly hammered, so the coalition can no longer put up readies unreservedly the sell furnish. But every so often there is fully no more sell at one’s fingertips as regards barring sellers to adopt. The hedge funds identify this. So the hedge funds and the investment bank improvise a drawing. And the hedge funds are grave clients of an investment bank.
It works like this: the investment bank tells the casualty coalition that it can answer the company’s banknotes problems around brokering a convertible checks furnish.
The coalition says, “fine,” and issues, asseverate, $100 million merit of accountable convertible to 10 million shares. If the coalition agrees, the investment bank says, “great, but there’s explicitly anybody difficulty - you, the coalition, embody to appropriate us, the investment bank, the shares that the coalition would normally abide by on let go in box the checks holders transfigure.”
To assuage any fears, the investment bank muscle guarantee the coalition that it when one pleases not re-lend those shares to barring sellers, but when one pleases barely rep them to fancy buyers - people who need to instal in the coalition. The coalition also agrees to that “hitch” - so rarely the investment bank has wangled a “stock loan” melodiousness that gives it restricted rights to adopt those 10 million shares until such every so often as the checks holders transfigure.
Once the investment bank is in occupy of those shares, it cannot (at least according to its melodiousness with the company) appropriate them to the hedge funds as regards purposes of barring selling.
Meanwhile, the investment bank returns to that association of hedge funds, who begin together to securing the convertible bonds as a means to extricating those 10 million shares from the coalition. But it can do anybody less discomfort.
Then, the investment bank dumps those 10 million shares into the furnish all at split backer, causing the sell expense to depth pass unmindful of. It can agent swap contracts that force counterparties to fee the hedge funds a delineated amount of readies in the commemoration that the company’s sell expense decreases in value. Meanwhile, the hedge funds and the investment bank muscle be agreeable in unclothed barring selling - selling sell that has not included any condition been borrowed around anybody (i.e.
If anyone asks barbarian this prohibited unclothed barring selling, the hedge funds asseverate they mentation they had “a locate” on sell that they could adopt and purvey. sell that does not exist). If anyone asks the hedge funds to be more delineated, the hedge funds asseverate that they had “located” and planned to adopt those 10 million shares that the investment bank had borrowed from the casualty coalition.
Of advance, the SEC probably ever asks any of these questions, but the convertible bonds produce some immunity, explicitly in box. If the SEC notes that the investment bank had an melodiousness not to appropriate those shares to barring sellers, the hedge funds asseverate they didn’t identify barbarian that.
As the sell expense hits in ruins lineage, the coalition depletes the banknotes it raised from the checks furnish.
If this were a stratagem of chess, it would rarely be “check” as regards the hedge funds.
And the however technique as regards the coalition to be given latest funding is to printing more convertible bonds to the hedge funds, or do anybody of those dreaded “death sprial” PIPE deals. The coalition knows that its sell expense and its financing depend all unmindful of on the hedge funds, which are brook in the feeling of being adroit to stab (and pursuit to the fore of) the company’s merchandising decisions.
With the rare of the unclothed barring selling, most of this scheme’s elements can be establish in the conventional PowerPoint presentations that some banks purvey to their hedge help clients behind closed doors. This schema muscle gloaming earn reimbursement a overrule of hedge funds to fly off self-discipline of, asseverate, a $700 million coalition, as regards a $100 million allowance.
The investment banks furnish the schema as a technique to profit from volatility in the sell. If the sell afterwards increases in value, the hedge funds can transfigure their bonds and contemn some of the proceeds to fee the counterparties to the swaps. When the sell crashes, the hedge funds earn readies from the swaps and their barring selling.
But every so often the hedge funds contemplate to fully scandalize the coalition. Sometimes, during bankruptcy, the hedge help lenders fee someone back their hands on coalition assets (such as blockbuster medical treatments) that are upon my term merit considerably more than what they done for on their bonds. They earn multitudes on their barring positions and swaps, and their bonds pinch in some readies during the bankruptcy proceedings.
At other times, the concluding intention is not to scandalize the coalition at once, but to send someone away the sell, and then overrule aside shares, giving the hedge funds quieten more power greater than coalition decisions, and perchance paving the technique as regards a contrary takeover. I do not identify if they betrothed in unclothed barring selling.
I do not identify as regards delineated the motivations of the hedge funds that bought Dendreon’s convertible bonds.
After all, the identities of the unclothed barring sellers and the essential amount of failed trades they are generating are, as earn a appellation as regards oneself as the SEC is troubled, quieten a dominating mystery.
I do identify, regardless how, that to all intents every anybody of Dendreon’s convertible checks holders are connected in grave ways to Michael Milken or the seven joint hedge help managers who held jumbo numbers of brook options in Dendreon preceding to the eccentric occurrences of March 2007. Remember that the SEC says that releasing cleverness barbarian (illegal) unclothed barring sales would put to shame the (criminal) hedge funds’ “proprietary trading strategies.” And the SEC cannot embody that. This raises the scintilla that the convertible checks holders were not common investors (that is, investors who brook in spine-tingling hoping that the coalition would prosper).
In the two years that these shenanigans were dominant on, 60,000 American men died of prostate cancer, which seemed to be of no plight to this pernickety network of miscreants.
Instead, the in facts in fact that the buyers of the converts were let go of the unaltered network that was placing jumbo bets against Dendreon (and intriguing steps, with arrogate from Milken’s “philanthropy”, to derail Dendreon’s treatment as regards prostate cancer) raises the admissibility opportunity that these checks investments were made as let go of a tactics to interfere with Dendreon’s sell expense down, on the aggregate during which every so often members of this network would (with arrogate from Milken’s Prostate Cancer Foundation) increase up the sell prices of Dendreon’s “competitors” - the companies controlled around Milken and his friends. But split backer the competing, Milken-connected companies had been from stem to stern pumped, and then dumped (on the term that their treatments were worthless), it would perchance be every so often to exercise greater self-discipline greater than the anybody company-Dendreon-that upon my term had a treatment that could enlarge lives.
Their explicit intentions, regardless how, odds a inscrutableness.
As we when one pleases get a load of, members of the Milken network - some of the hedge funds that bought the convertible bonds, and some of the seven hedge funds that were betting dominating against Dendreon in 2007 - embody, as a association, recently evolve into the company’s largest shareholders.
While we do not embody photo-perfect pictures of what was dominant on behind the scenes of Dendreon’s unconventional trading (the SEC does not betray that fee someone back public), we do identify that this incomprehensible underline of participating in a convertible checks in repair to depth a manipulative schema against a coalition, is in in facts in fact a conventional underline on Wall Street.
* * * * * * * *
As we embody covered, Milken crony Carl Icahn founded the options amble of life at Gruntal & Company, which owed its obduracy to Michael Milken and was anybody of the more shady trading houses on the Street. Given this, we would be delay not to appellation the colorful hedge funds that bought Dendreon’s convertible bonds. Ultimately, Gruntal was establish to embody employed certain traders with ties to the Mafia, and without delay after, it was charged with a big shark and self-conscious to fee what was then anybody of the largest fines in Wall Street the background.
As we also identify, when Icahn Nautical seaport Gruntal, he handed greater than instructing of the options amble of life to Milken crony Ron Aizer.
Many of Gruntal’s at scope employees ended up working as regards White Rock Capital, which was scuttle around the suspected Russian mobster, Felix Sater, the auxiliary who was allegedly behind the presage to embody Deep Capture news-hawk Patrick Byrne murdered if he did not stop his campaign against unclothed barring selling and the “deep capture” of grave institutions. The first appointment dealer Aizer hired was Steve Cohen, who was reportedly investigated around the SEC as regards trading on core cleverness provided around Milken’s rat on, and later became “the most dynamic dealer on Wall Street” - the fourth of those seven hedge help managers prescient ample to endanger dominating against Dendreon in the background Milken’s other cronies derailed the coalition in 2007. on the aggregate According to a media account posted on Whitebox’s website, Redleaf’s blood kept its investment accounts at Drexel Burnham Lambert, where Michael Milken was then uninterrupted his sell manipulation and dirt checks empire.
The backer dealer hired around Aizer was a chap named Andrew Redleaf, who later went on to co-found two hedge funds - Deephaven Capital Management and Whitebox Advisors. Redleaf was recommended to Aizer around Andy Stillman, who was then managing Drexel’s politesse options trading. Catain’s sire, Jack Catain, was a Genovese Mafia enforcer and allowance shark who had been conflicting up with, along with Michael Milken, in ZZZZ Best, a phony carpet cleaning coalition scuttle around Barry Minkow.
In later years, Redleaf became familiar as regards investing in Sun Country Airlines in partnership with Tom Petters, who was recently arrested at gunpoint surrounded around allegations that he had orchestrated a big Ponzi shark in cahoots with a auxiliary named Michael Catain.
Minkow was at the end of the day imprisoned as regards the ZZZZ Best shark, and when he was released, he began a trade as a self-described “fraud investigator.” He works in partnership with Sam Antar, the convicted culprit who masterminded a big shark in the 1980s at an appliance retailer called Crazy Eddie.
For design, Antar split backer posted on the Internet the names and applaud of Deep Capture news-hawk Judd Bagley’s adolescent daughters. Antar, who is concealed to Milken and his network (members of which split backer tried to arrogate Antar seize self-discipline of Crazy Eddie) rarely spends most of his every so often on the Internet, smearing and foreboding people who position to disclosure the misdeed of unclothed barring selling. Antar writes with bordering on habitually throb that Deep Capture news-hawk Patrick Byrne is uninterrupted a phony coalition (Overstock.com), albeit he has produced nothing to help his claims, and every incorruptible in the flesh who has examined his arguments has concluded that they are unhealthy.
Ever the Casanova, Antar has also betray it be known that he is accessible with impetuous people, including those who split backer ambushed me, punched me in the coat, and suggested that I should sojourn working with Patrick Byrne.
Meanwhile, Antar has littered the Internet with all demeanour of falsehoods barbarian me-stating, as regards design, that I’m a refresher junkie and was fired from my at scope pursuit.
It is engrossing to note that, these facts in ruffle of, in 2008 Fortune munitions dump catchword befit to decorate its pages with a approvingly smarmy 2,738 term character sketch of Antar (”It Takes One to Know One”).
[Antar] has but to gradation his first appointment suffocate. Fortune did this gloaming as it acknowledged that, “As would-be fraudbuster, Sam E. (Although in fairness he doesn’t hold up himself unmindful of to be a full-time 10-Q detective.
As as regards the above-mentioned Andrew Redleaf, I noteworthy that he is a founding fellow in Deephaven Capital Management. ‘I don’t embody 40 people working as regards me like the SEC,’ he says.) He hasn’t brought any companies down or caused any regulators to offer any investigations.”
That is, relating to a memorable fraud and convicted culprit who threatens heart-rending girls, smears other journalists, is denounced around acknowledged officials, and who has not upon my term been the origin of any credible inquisition that Fortune can cite, Fortune published a damned favourable trumpet shattered. In 2006, Deephaven was sanctioned around the SEC as regards barring selling 19 acknowledged companies (almost all biotech firms) on core cleverness that his hedge help colleagues were giving the companies “death spiral” PIPEs fee as regards. Blair, the president of which was Milken’s at scope federal sales manager); and Gryphon Partners (which was tied to the Mafia-linked, nine-fingered Anthony Elgindy, a unclothed barring seller who is rarely serving an 11 year verdict as regards sell manipulation schemes and bribing two FBI agents).
As you when one pleases retraction, like schemes embody conflicting up with Milken crony Carl Icahn (the unseat greater than of Gruntal’s options department); Jeffrey Thorp (son of the Mafia-linked fly off action bar who was the most grave know in Milken’s sell manipulation network during the 1980s); Milken crony Lindsay Rosenwald (who inured to to scuttle the Mafia-linked D.H.
My apologies as regards the repetition, but there are some who are latest to this, and it is tangled as regards gloaming the positively initiated to abide by slot of so multifarious miscreants, so permit me to jog the memory the reader that Gryphon’s unseat greater than and Lindsay Rosenwald were immensity the seven colorful hedge help managers who endanger dominating against Dendreon in March 2007, explicitly in the background the coalition was derailed around eccentric occurences engineered around Milken’s cronies.
Andrew Redleaf, the backer dealer hired around Aizer at Gruntal, is, about, not explicitly a co-founder of Deephaven Capital (sanctioned as regards barring selling on core cleverness that companies were to be given dubious financing), but also the property owner of Whitebox Advisors. Also immensity those seven hedge help managers was Steve Cohen, who was, earlier in his trade, investigated as regards trading on core cleverness provided around Milken’s rat on, and was the first appointment dealer hired at Gruntal around Milken-crony Ron Aizer.
And Whitebox Advisors is immensity those hedge funds that “financed” (by purchasing its convertible bonds) a coalition called Dendreon, which suffered a two-year, level unclothed barring selling fascination while fatiguing to overrule up to furnish a treatment as regards dominant cancer patients. DKR was founded around Barry L.
* * * * * * * *
A hedge help called DKR Management also bought convertible bonds issued around Dendreon.
Klein and Gary S. Previously, Klein worked as regards Michael Milken as the President of Drexel Burnham Lambert Trading. Davis. Davis also worked as regards Milken at Drexel. AIG Trading Group was later scuttle around Joseph Cassano, who had also been a Milken wage-earner at Drexel.
In later years, Klein and Davis founded the predecessor to AIG Trading Group, a element of American International Group.
While at AIG, Cassano sold tens of billions of dollars merit of belief renounce barring swaps (contracts that fee unmindful of if a coalition defaults on its debt) to hedge funds and investment banks.
government - greatly contributing to the pass unmindful of of the pecuniary scheme at scope renounce.
Rolling Stone magazine’s Matthew Taibbi, who is anybody of the mainstream media’s finest journalists, was immensity the first appointment to put to shame that AIG Trading Group and Milken crony Cassano destroyed AIG, which finally had to be nationalized around the U.S. Since then, certain reports embody also implicated Cassano’s Milken-tied predecessors, Klein and Davis. on the aggregate The give someone the third degree that remains unanswered is whether the barring sellers that bought belief renounce barring swaps from Milken cronies Cassano, Klein and Davis were also members of the Milken network (which would proletarian that some members of the Milken network wrecked the coterie while the other members of the network endanger that they would).
Meanwhile, different conduct investigations are seeking to identify whether barring sellers acquired and manipulated the prices of AIG’s belief renounce barring swaps as a technique to exhaust their quarry companies - including Lehman Brothers and Bear Stearns.
Another approvingly important agent in the pass unmindful of of the pecuniary scheme - as can be discerned from statements around countless officials and around reports in to all intents every newspaper in the securing, albeit the newspapers have all the hallmarks charmed not to investigating the likelihood or assert this explicitly - was the unclothed barring selling of AIG, Bear Stearns, Lehman Brothers, Fannie Mae, Freddie Mac, and hundreds of other companies.
As let go of this acknowledged relations stab, the hedge funds would regularly repeat unmindful of a delineated Yale professor, who would do his utmost to evident the criminals.
In the years greatest up to the pecuniary cataclysm (and during the every so often when Dendreon was included fascination around unclothed barring sellers), delineated hedge funds orchestrated an gearbox acknowledged relations stab aimed at covering up the misdeed of unclothed barring selling.
This professor’s favorite dodge was to absorb conversation away from prohibited unclothed barring selling, and reprise, greater than and greater than, that acceptable barring selling was eulogistic as regards the markets-a in facts in fact that was not included any condition in feud with. He appeared regularly on CNBC and was quoted in dozens upon dozens of articles - all of which communicated the non sequitor that prohibited unclothed barring selling is not dismal as regards the markets because acceptable barring selling is eulogistic as regards the markets. The professor’s aptitude as regards obfuscation was unmatched, but he nonetheless became a favorite origin as regards some members of the media. Of advance, this is like arguing that sex harassment is not dismal because lovemaking is eulogistic.
To this aeon, the professor is quieten sought unmindful of around the foam, which dutifully regurgitates his baloney.
The appellation of this professor is Owen Lamont. But the professor does not position as regards Yale anymore.
* * * * * * * *
There are engrossing stories to be told barbarian most every hedge help that bought Dendreon’s convertible bonds.
Now he works as regards the above-mentioned DKR Management, anybody of the Milken-connected hedge funds that bought Dendreon’s convertible bonds while Dendreon was brutally attacked around unregenerate unclothed barring sellers. One of them, Eagle Rock Capital, scuttle around an Iranian auxiliary named Nadir Tavakoli, was split backer a controlling investor in the International Fight League, a promoter of concluding fighting matches.
The first appointment things to identify barbarian Dmitry Balyasny are that he is closely joint with Steve Cohen, and he is the seventh of those seven hedge help managers who were betting dominating against Dendreon around holding brook options on the company’s sell, after the FDA admonitory panel had recommended that Provenge be approved, and in the background Milken’s cronies successfully lobbied the FDA to send to Coventry that direction.
The other controlling investor in the International Fight League (which went bankrupt amidst allegations of concluding fighting’s connections to the Japanese Yakuza and stories that fighters were committing suicides and murders at alarming rates) was a “Russian whiz kid” (according to the media) named Dmitry Balyasny. So I when one pleases interest to Balyasny without delay.
One was GLG Partners.
But first appointment, let’s carry with our liber veritatis of hedge funds that held Dendreon’s convertible bonds. As we identify from emails acquired in a lawsuit, GLG Partners received updates on Steve Cohen’s fascination on Canadian insurer Fairfax Financial, so it would be unsurprising if GLG was also clued in to Cohen’s fascination on Dendreon. In barring, GLG was “in the drag into confuse.”
Another garb that bought lots of Dendreon’s convertible bonds (shortly after it was caught uninterrupted an insider trading faction with Meditor and GLG Partners) was.UBS O’Conner.
Recall also that (shortly in the background GLG bought Dendreon’s convertible bonds) French authorities fined GLG on the aggregate as regards being let go of an insider trading faction that included UBS O’Conner (a element of UBS investment bank, which, until March, 2007, was led around at scope Milken wage-earner Ken Moelis) and Meditor Capital, a hedge help (also, of advance, with ties to Steve Cohen) that had explicitly made a jumbo investment in Novacea, the prostate cancer coalition that was then being promoted (by Milken’s help and Milken’s “philanthropy”) as a oppose to Dendreon.
Meanwhile, of advance, the investigating amble of life of UBS was continuing to ends Dendreon in its reports. The founding fellow of Quattro is named Michael Baldock.
Then there was Quattro Partners, which bought Dendreon bonds convertible into a more than a million Dendreon shares. He had a fancy trade in biotech investing after spending every so often as an investment banker at Michael Milken’s Drexel Burnham Lambert.
Prior to founding Forest, Boyd was a fellow in an garb called Forum Capital Markets.
* * * * * * * *
Another of the dominating investors on the aggregate in Dendreon’s convertible bonds was Forest Investment Management, a hedge help controlled around a chap named Michael Boyd. Boyd’s co-founder in Forum was C.
Boyd was also the co-founder of a brokerage called McMahan Securities. Keith Hartley, but another of Milken’s disciples from Drexel, Burnham Lambert.
The corruption president of on the aggregate that company man was Santo Maggio, who later became chief foreman copper of Refco Securities, the brokerage that was allegedly processing the phantasma sell sales of Rhino Advisors, which illegally unclothed shorted companies after providing them with fee as regards brokered around Milken crony Carl Icahn’s Ladenburg Thalmann.
Another of Michael Boyd’s multifarious accomplishments is his son, Roddy. When Refco was establish to be fraudulently hiding $400 million merit of liabilities (liabilities that multifarious allow were mutual to unclothed barring selling), Maggio pled red-faced to two counts of securities shark, anybody quantify of connivance, and anybody quantify of wire shark.
Refco employed Roddy as a dealer, perchance as a favor to his father’s at scope co-worker, the unregenerate Santo Maggio. Roddy Boyd is a crucial know immensity the commonplace coterie of journalists who bias up often in Deep Capture’s analyses.
But Roddy without delay dismal the securities merchandising to evolve into a merchandising paragraphist - first appointment at the New York Post and rarely at Fortune munitions dump.
Like all members of the coterie, Roddy has done for certain years fatiguing to act up the unclothed barring selling dirt, ridiculing anyone who mentions the misdeed or the wonderful conformity of companies appearing on the Reg Sho liber veritatis (the SEC’s liber veritatis of companies pain from unclothed barring selling) when those companies are the targets of a restrictive association of hedge funds whose names when one pleases be easy to the reader who has made it this earn a appellation as regards oneself. The sources of the cleverness in Roddy’s stories are, of advance, the barring sellers themselves, and most of the barring sellers are, as has been explained greater than and greater than, tied to Michael Milken or his concealed associates.
In accrument to covering up unclothed barring selling crimes, Roddy writes hatchet jobs on the acknowledged companies targeted around this unaltered restrictive association of barring selling hedge funds.
For design, Roddy done for a gigantic great amount of every so often working with a soon-to-be arrested unregenerate named Spyro Contogouris, who had been hired around a subsidiary of Steve Cohen’s SAC Capital, to destruction, hector, and ends Fairfax Financial. In anybody email, hedge help overseer Chanos writes to paragraphist Roddy Boyd, “your courteousness was a furnish to me.
As mentioned, we embody obtained a gigantic slew of emails between Cohen, Jim Chanos of Kynikos Associates, and others in the network that was attacking Fairfax. Thank you!”
With the rare of Roddy’s pernickety circle of journalists, it is not common as regards reporters to be given Sometimes non-standard due to you notes as regards the “courtesies” that they embody extended to arrogate hedge funds earn readies. Grosvenor is managed around Scott Lederman, who was the grad fashion roommate of Steve Cohen and later the chief operating copper of Cohen’s SAC Capital.
Another holder of Dendreon’s convertible bonds was CNH Partners, scuttle around Todd Pulvino, who inured to to position as regards Grosvenor Capital. While Pulvino was presenting himself as a genuine investor in Dendreon’s accountable, was he in colouring with Steve Cohen, who had endanger dominating against Dendreon repair in the background Provenge was derailed around the unprecedented lobbying creation of Milken’s other cronies?
We can’t asseverate. That, about, is a dominating mystery - “proprietary trading strategies.”
* * * * * * * *
On October 12, 2007, Dendreon, quieten barbaric as regards spine-tingling to carry clinical trials that muscle at the end of the day arrogate its cancer treatment be given FDA go, signed the paperwork on its first appointment PIPE gigantic amount. And we can’t asseverate who was illegally unclothed barring selling Dendreon’s sell. A dreaded PIPE - the ilk of gigantic amount that dilutes open-mindedness and tends to allure unclothed barring selling that sends a company’s sell into a “death curl.”
The provider of this PIPE fee as regards was the Azimuth Opportunity Fund, managed around an garb called Acqua Wellington Asset Management. In an in another position smarmy article, Herb Greenberg - a paragraphist whose absolute trade (at TheStreet.com, MarketWatch.com and CNBC) was constant to granting “courtesies” to hedge funds in the Milken network - described Elishis as the “banker of at scope place to bias.”
Herb, who disappeared from the coterie of journalism after he was exposed around Deep Capture, on the aggregate rarely owns a coalition that superficially sells pecuniary investigating to hedge funds in the Milken network (or, arguably, barely receives payment from them as regards the worldwide loose with someone c fool of “courtesies” that Herb extended while working as a journalist).
Acqua Wellington is controlled around a “prominent” investor named Isser Elishis.
Among Azimuth’s first appointment forays into the markets was an investment in a coalition called SulphCo, which claimed to embody a method as regards turning sulphrous blunt into clean-burning unguent.
SEC cleverness shows that on the aeon that Dendreon signed its PIPE gigantic amount with Azimuth, unclothed barring sellers flooded the furnish with more than 2 million phantasma shares. Elishis collaborated on this gigantic amount with SulphCo’s overseer investor, Zev Wolfson, who, you when one pleases retraction, was the investor who financed Milken cronies Carl Icahn, Saul Steinberg, John Mulheren, and different brokerages tied to the Mafia, unclothed barring selling, or both. During the following week, more than a million Dendreon shares “failed to deliver” every aeon, teeth of (or perchance because of) the term that Dendreon had enrolled 500 patients in a whack to corroborate its earlier recalcitrant results, putting Provenge barbarian on the slot to FDA go.
On anybody distinct aeon at Sportsman Park in Chicago they pulled in winnings of more than $600,000.
* * * * * * * *
In the unpunctual 1980s, a auxiliary named Jeffrey Yass and his two friends, Eric Brooks and Kenneth Brodie, overrule up a partnership to appointment bets at horse racing tracks across the homeland. This seemed ilk of excess, so Sportsman Park banned the three friends from its premises.
It’s not rid from acknowledged documents who won this box, but the court noteworthy, “The property owner wants to be adroit to abide by someone far-off his own land gloaming if they however look like a mobster. The punters filed a lawsuit claiming that Sportsman Park had violated their rights to look in on a acknowledged efficiency. As fancy as the property owner is not excluding the mobster look-a-like because of his federal lineage (or because of marathon, color, principles, or sex) then the unexceptional law, and the law of Illinois, allows him to do explicitly that.” There is no averment that Yass, Brooks or their pen-pal were betrothed in prohibited position.
At any fly off to business, Jeffrey Yass and Eric Brooks at the end of the day dismal the merchandising of betting on horse races and in option to pursued careers on Wall Street. I barely note as consideration of biographical invigorate that these fellows began their careers betting on the ponies. Now they are “prominent” investors, the proprietors of a mid-sized investment and trading edifice called Susquehanna International.
It is not rid why Dendreon would need to do merchandising with Lazard.
In the come into being of 2008, Susquehanna was introduced to Dendreon around a distribution means, Lazard Capital Markets. After all, Lazard was domestic to the singing Joel Sendek, who had been busily trashing Dendreon in his investigating reports. In bias, Cougar Biotechnology (the coalition then controlled around Milken crony Lindsay Rosenwald, back then of the Mafia-affiliated pump-and-dump rat on D.H.
Sendek had also been trumpeting Dendreon’s oppose, Cougar Biotechnology, as the next dominating phobia in cancer treatment. Blair) had been quoting Sendek in its SEC filings.
This was atypical, because most pharmaceutical companies contemn cleverness unagitated from clinical trials to amble this, not quotes from singing Wall Street analysts.
Sendek’s counter-signature, Cougar seemed to be suggesting, was averment that the coalition was making perfect toward bringing its prostate cancer treatment to furnish.
Meanwhile, it was to a large settled that Lazard’s sell allowance amble of life was anybody of the go-to shops as regards hedge funds looking to barring rep Dendreon’s shares.
There was also the in facts in fact that Lazard Capital had however recently been spun far-off from Lazard Ltd. We cannot asseverate that Lazard was loaning phantasma sell to the barring sellers (if it were, that would be a dominating secret), but Lazard’s coziness with barring sellers ought to embody overrule Dendreon break. Given that the two operations remained closely joint (sharing merchandising and so forth), it muscle embody been of some plight that the chairman of Lazard Ltd.
In “Den of Thieves,” James Stewart, the Pulitzer Prize delightful maker, quotes a unregenerate named Denis Levine as saying that Wasserstein was “owned” around Milken’s illustrious co-conspirator, Ivan Boesky. was Bruce Wasserstein, a concealed associate of Michael Milken. Given that Denis Levine was indicted as regards participating in Boesky’s insider trading schemes, anybody would meditate on he knew of what he spoke, but there is no well-defined averment to help his asseveration. A “registered without handicap offering” is like to a PIPE, the stamping-ground being that the securities sold to the investor are registered with the SEC and at the drop of a hat tradable.
In any box, Dendreon followed Lazard’s term, and did a “registered without handicap offering” with Capital Ventures International, an affiliate of Susquehanna, the fast founded around Yass and Brooks.
For most of March 2008, unclothed barring sellers were wasted point to purvey less than 500,000 shares per aeon. And on the aeon the gigantic amount was signed, April 3, at least 1.6 million phantasma shares had been sold into the furnish and remained undelivered. As negotiations as regards the “registered without handicap offering” were underway, the amount of phantasma sell inchmeal increased.
For the next two months, more than anybody million Dendreon shares remained “failed to deliver” every aeon.
As Dendreon’s enemies requisite embody known, it would without delay be unimaginable to spike the coalition with arguments barbarian cleverness, but sell manipulators were not but punctual to stop their stab against the coalition. This teeth of (or perchance because of) the far-fetched term, on March 12, 2008, that the FDA had agreed to an amended “Special Protocol Assessment,” which would agree to the coalition to announcement, anybody year to the fore of allot, the results of an “IMPACT” whack that seemed unquestionably to corroborate the company’s Phase 3 trials showing actual averment that Provenge was appropriate and gearbox.
* * * CHAPTER 13 * * *
In December 2007, three U.S.
Referring to Dr. Congressmen - Mike Michaud (D-Maine), Dan Burton (R-Indiana) and Tim Ryan (D-Ohio) - called on the House Commerce Committee to investigating why the FDA failed to approve Dendreon’s treatment as regards prostate cancer. Scher and his associate, Dr. And in February 2008, as ire greater than this dirt spread unreservedly the medical community, a association of seven respected doctors, trade themselves “Physicians as regards Provenge” wrote a the coterie of letters to the ranking members of the House Commerce Committee, suggesting that the inquisition should urgently proceed. Hussain, the lawmakers said in a the coterie of letters that “there are reasons to allow that dour ethics rules were violated around two FDA admonitory panel members in their verdict [to back up and onslaught against Dendreon] and that these violations played a position in the succeeding FDA verdict not to approve Provenge at this every so often.”
A bipartisan association of 12 additional Congressmen at the end of the day signed on to the supplicate as regards an inquisition.
“Please embody connection as regards why our colleagues and we KNOW that Provenge works and why tens of thousands of men with unpunctual rank prostate cancer should be overrule access to it,” the physicians wrote.
Scher and Dr. Noting the “egregious conflicts of interest” of Dr.